LncRNA name,Cancer name,Methods,Expression pattern,Pubmed ID,Remarks,No. of Lnc Transcript variants,NCBI Reference Number,Total No. of PQS,No. of 2G PQS,No. of 3G PQS,No. of 4G PQS,RefSeq status,Total No. of PQS.1,G4Hunter Scores of PQS,Similarity between PQS from QGRS mapper vs PQS from G4 hunter,Total No. of PQS.2,G4Hunter Scores of PQS.1,Similarity between PQS from QGRS mapper vs PQS from G4 hunter.1,Unnamed: 19,aka
AATBC,nasopharyngeal cancer,"Western blot, qRT-PCR, Luciferase reporter assay etc.",up-regulated,32364663.0,,1,NR_026961.1,66,59,7,0,VALIDATED,"31 (7 - 2G, 6 - 3G, 3 - 4G, 15 - C-rich)","[-0.958, -0.957, -0.817, -0.978, -0.813, -0.828, -0.911, -0.875, -0.911, -1, -0.744, -0.9, -0.815 (C-rich), 0.738,  0.557, 0.913, 0.938, 0.915, 0.909, 0.935, 0.803, 0.898 (2G), 0.918, 0.825, 1.042, 1, 0.872, 1.059 (3G), 1.117, 1.042, 1.155 (4G)]","PQS 19 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 28 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 28 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

PQS 34 (3G) of QGRS mapper and the PQS 17 (3G) of G4 hunter have similar G tracts.

PQS 37 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) from G4 hunter has a left frame-shift as compared to PQS 37 (3G) from QGRS mapper.

PQS 45 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 46 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","17 (11 - 2G, 3 - 3G, 3 - C-rich)
","[1.327, 1.28, 1.422, 1.4, 1.383, 1.348,  1.4, 1.24, 1.25, 1.391, 1.4 (2G), 1.26, 1.4, 1.313 (3G), -1.288, -1.391,-1.37 (C-rich)]","PQS 37 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts. 

PQS 37 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.  ",,apoptosis associated transcript in bladder cancer;apoptosis-associated transcript in bladder cancer;AATBC;HSALNG0133454;NONHSAG032997.2;HSALNG0133458
ADAMTS9-AS2,tongue squamous cell carcinoma,"qPCR, Microarray, Western blot",up-regulated,30970517.0,,1,NR_038264.1,12,11,1,0,VALIDATED,"5 (1 - 2G, 1 - 3G, 3 - C-rich) 
","[0.872 (2G), 0.902 (3G), -0.987, -0.904, -0.945 (C-rich)]",PQS 4 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.,1 (C-rich),[-1.392 (C-rich)],"No similarity to 
any PQS from QGRS mapper",,ADAMTS9 antisense RNA 2;ADAMTS9 antisense RNA 2 (non-protein coding);NONHSAG035335.2;ADAMTS9-AS2;HSALNG0026583;HSALNG0026595;lnc-ATXN7-15;HSALNG0026585
AFAP1-AS1,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,29971915.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,31875436.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, other",up-regulated,30326930.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,tongue squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown",up-regulated,29310682.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,nasopharyngeal cancer,qPCR etc.,down-regulated,28467811.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,nasopharyngeal cancer,"Microarray, qPCR, RNAi, Western blot, ISH etc.",up-regulated,26246469.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
AFAP1-AS1,laryngeal squamous cell cancer,"qPCR, Luciferase reporter assay, Western blot, etc.",up-regulated,29971915.0,"Also Known As: AFAP1-AS, AFAP1AS
",1,NR_026892.1,37,36,1,0,REVIEWED,"9 (1 - 3G, 8 - C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872 (C-rich), 0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 Hunter,,AFAP1AS; AFAP1-AS
ANCR,nasopharyngeal cancer,"qPCR, Western blot, RIP, etc.",up-regulated,30568463.0,"Also Known As: AGU2; ANCR; DANCR; 
SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, 
Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete 
sequence-LC128577.1, LC128578.1 and 
LC128579.1 respectively) with PQS- 7, 7, 7 
respectively, were also there in result.",3 (DANCR),"DANCR (NR_024031.2, NR_145129.1, NR_145130.1)","6, 7, 7 (DANCR)","5,6,6","1,1,1","0,0,0",REVIEWED (DANCR),"3 (3 - C-rich);

1 (C - rich);

1 (C - rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62 (C-rich)];

[-0.62 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"1 (C-rich);

1 (C-rich);

1 (C-rich);","[-1.444 (C-rich)];

[-1.444 (C-rich)];

[-1.444 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
ANRIL,laryngeal squamous cell cancer,"RT-qPCR, Western blot, Dual luciferase reporter assay",up-regulated,31960744.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,laryngeal squamous cell cancer,"Dual luciferase reporter assay, qRT-PCR, Western blotting",up-regulated,31667207.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,30555745.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,oral squamous cell carcinoma,"RNA-seq, qPCR, Western blot",up-regulated,31364119.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,oral squamous cancer,"qPCR, Western blot, etc.",down-regulated,29176691.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,laryngeal squamous cell cancer,qPCR etc.,up-regulated,25257554.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,oral cancer,"qPCR, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29635126.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,nasopharyngeal cancer,"RT-qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,29463902.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,nasopharyngeal cancer,"qPCR, RNAi, Luciferase reporter assay, MTT assay etc.",up-regulated,28117929.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,nasopharyngeal cancer,"qPCR, Luciferase reporter assays",up-regulated,28402230.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ANRIL,nasopharyngeal cancer,"qPCR, RNAi, Western blot, MTT assay etc.",up-regulated,27557514.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
BANCR,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,31654433.0,Also Known As: LINC00586,1,NR_047671.2,4,4,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,LINC00586
BC200,tongue cancer,"Northern hybridization, ISH etc.",up-regulated,9422992.0,Also Known As: BCYRN1; BC200; BC200a; LINC00004; NCRNA00004,1 (BCYRN1),BCYRN1 (NR_001568.1),2 (BCYRN1),2,0,0,REVIEWED (BCYRN1),1 (C-rich),[-1.135 (C-rich)],No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,BC200; BC200a; LINC00004; NCRNA00004
BLACAT1,head and neck squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,31944856.0,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2 - 2G, 4 - C-rich)","[0.821, 0.922 (2G), -0.815, 0.603, -0.938, -0.891 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT1 overlapping LEMD1 locus;linc-UBC1;LINC00912;onco-lncRNA-30;long intergenic noncoding RNA up-regulated in bladder cancer;long intergenic non-protein coding RNA 912;bladder cancer associated transcript 1 (non-protein coding);bladder cancer associated transcript 1;NONHSAG004054.2;HSALNG0009941;BLACAT1;Bladder cancer-associated transcript 1
BLACAT1,oral squamous cell carcinoma,"qRT-PCR, Luciferase Reporter Assay, Western blot Assay",up-regulated,31841186.0,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2 - 2G, 4 - C-rich)","[0.821, 0.922 (2G), -0.815, 0.603, -0.938, -0.891 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT1 overlapping LEMD1 locus;linc-UBC1;LINC00912;onco-lncRNA-30;long intergenic noncoding RNA up-regulated in bladder cancer;long intergenic non-protein coding RNA 912;bladder cancer associated transcript 1 (non-protein coding);bladder cancer associated transcript 1;NONHSAG004054.2;HSALNG0009941;BLACAT1;Bladder cancer-associated transcript 1
C5orf66-AS1,oral squamous cell carcinoma,"qPCR, Western blot, other",down-regulated,30280186.0,Also known as: Epist,2,"NR_105049.1, NR_105050.1","9,9","8,8","1,1","0,0",VALIDATED,"8 (1 - 3G, 7 - C-rich);

8 (1 - 3G, 7 - C-rich)","[-0.915, -0.957, -0.935, -1.021, -1.261, -0.828, -0.982 (C-rich), 0.979 (3G)];  

[-0.915, -0.957, -0.935, -1.021, -1.261, -0.828, -0.982 (C-rich), 0.979 (3G)]",PQS 1 (3G) of G4 Hunter and PQS 1 (3G) of QGRS mapper is similar and the main G tract of both PQS is the same with a right frame shift in G4 hunter compared to QGRS mapper.,"1 (C-rich);

1 (C-rich)","[-1.505 (C-rich)]; 

[-1.505 (C-rich]",No similarity to any PQS (2G) from QGRS mapper,,C5orf66-AS1
C5orf66-AS1,oral squamous cell carcinoma,qPCR,differential expression,28415559.0,Also known as: Epist,2,"NR_105049.1, NR_105050.1","9,9","8,8","1,1","0,0",VALIDATED,"8 (1 - 3G, 7 - C-rich);

8 (1 - 3G, 7 - C-rich)","[-0.915, -0.957, -0.935, -1.021, -1.261, -0.828, -0.982 (C-rich), 0.979 (3G)];  

[-0.915, -0.957, -0.935, -1.021, -1.261, -0.828, -0.982 (C-rich), 0.979 (3G)]",PQS 1 (3G) of G4 Hunter and PQS 1 (3G) of QGRS mapper is similar and the main G tract of both PQS is the same with a right frame shift in G4 hunter compared to QGRS mapper.,"1 (C-rich);

1 (C-rich)","[-1.505 (C-rich)]; 

[-1.505 (C-rich]",No similarity to any PQS (2G) from QGRS mapper,,C5orf66-AS1
CACS15,oral squamous cell carcinoma,qPCR etc.,up-regulated,31793142.0,Also Known As: CACS15 [mentioned in title of paper (PubMed-31665008) refereed in NR_015410.2]; CASC15; CANT; LINC00340; lnc-SOX4-1,1 (CASC15),CASC15 (NR_015410.2),18 (CASC15),18,0,0,REVIEWED (CASC15),0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,CANT; LINC00340; lnc-SOX4-1
CASC2,oral squamous cell carcinoma,"RT-qPCR, Western blot",down-regulated,32009793.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15,15,7","2,2,2","0,0,0",VALIDATED,"7 (4 - 3G, 3 - 2G);

7 (4 - 3G, 3 - 2G); 

6 (4 -3G, 2 - 2G)","[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, PQS 2 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.","0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,C10orf5
CASC2,oral squamous cell carcinoma,"qRT-PCR , Luciferase reporter assay , Western blot etc.",down-regulated,31123403.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15,15,7","2,2,2","0,0,0",VALIDATED,"7 (4 - 3G, 3 - 2G);

7 (4 - 3G, 3 - 2G); 

6 (4 -3G, 2 - 2G)","[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, PQS 2 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.","0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,C10orf5
CASC2,oral squamous cell carcinoma,"qPCR, other",down-regulated,30467776.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15,15,7","2,2,2","0,0,0",VALIDATED,"7 (4 - 3G, 3 - 2G);

7 (4 - 3G, 3 - 2G); 

6 (4 -3G, 2 - 2G)","[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, PQS 2 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.","0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,C10orf5
CASC2,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, RIP, etc.",down-regulated,30569153.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15,15,7","2,2,2","0,0,0",VALIDATED,"7 (4 - 3G, 3 - 2G);

7 (4 - 3G, 3 - 2G); 

6 (4 -3G, 2 - 2G)","[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, PQS 2 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.","0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,C10orf5
CASC2,oral squamous cell carcinoma,"qPCR, Western blot",down-regulated,31210307.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15,15,7","2,2,2","0,0,0",VALIDATED,"7 (4 - 3G, 3 - 2G);

7 (4 - 3G, 3 - 2G); 

6 (4 -3G, 2 - 2G)","[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891, 0.707 (2G)];

[1.043, 0.746, 0.956, 0.956 (3G), 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, PQS 2 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.","0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,C10orf5
CASC9,tongue squamous cell carcinoma,qRT-PCR,up-regulated,32021442.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CASC9,nasopharyngeal cancer,"qRT-PCR, Western blot, Luciferase activity assay, RIP",up-regulated,31933798.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CASC9,laryngeal cancer,qRT-PCR,up-regulated,31669650.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CASC9,head and neck squamous cell carcinoma,"qPCR, other",down-regulated,31412811.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CASC9,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30674868.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CASC9,nasopharyngeal cancer,"qPCR, Western blot",up-regulated,28398871.0,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0;

0;

1 (C-rich)","0;

0;

[-0.857 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1
CCAT1,oral squamous cell carcinoma,"qRT-PCR, Western blot, RIP",down-regulated,32009633.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,nasopharyngeal cancer,"qPCR, other",up-regulated,30013670.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,oral squamous cell carcinoma,"qPCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31599709.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,head and neck squamous cell carcinoma,"Microarray, qPCR etc.",differential expression,28159935.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,oral squamous cell carcinoma,qPCR,up-regulated,28413645.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,laryngeal squamous cell cancer,"qPCR, Western blot",up-regulated,27830017.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,nasopharyngeal cancer,"qPCR, western blot, luciferase reporter assay, MIT",differential expression,28358263.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,laryngeal squamous cell cancer,"qPCR, western blot, Luciferase reporter assays etc.",up-regulated,28631575.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,nasopharyngeal cancer,"qRT-PCR, ect.",up-regulated,30013670.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,CARLO5; CARLo-5; onco-lncRNA-40
CCAT2,oral squamous cell carcinoma,qPCR etc.,up-regulated,27220388.0,"Also Known As: NCCP1; LINC00873

Some (older-not checked for PQS) CCAT2 short and long variants ncRNA; ""other"" ncRNA (complete sequence - GQ911591.1 and GQ911592.1 respectively) were also there in result.",1,NR_109834.1,6,6,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,NCCP1; LINC00873
CCAT2,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,28671055.0,"Also Known As: NCCP1; LINC00873

Some (older-not checked for PQS) CCAT2 short and long variants ncRNA; ""other"" ncRNA (complete sequence - GQ911591.1 and GQ911592.1 respectively) were also there in result.",1,NR_109834.1,6,6,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,NCCP1; LINC00873
CCHE1,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,31981240.0,Also Known As: CCEPR; CCHE1; lncRNA-CCHE1,1 (CCEPR),CCEPR (NR_131782.1),17 (CCEPR),17,0,0,VALIDATED (CCEPR),"2 (1 - 2G, 1 - C-rich)","[-0.939 (C-rich), 0.894 (2G)] 
","No similarity to any PQS (2G)  from QGRS mapper
",0,0,No PQS found in G4 Hunter,,CCHE1; lncRNA-CCHE1
CDKN2B-AS1,laryngeal squamous cell cancer,"qRT-PCR, Western blot, RIP",up-regulated,31754305.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14,"(NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6","21,16,10,10,9,7,9,7,17,10,10,8,6,6","0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",[-0.829 (C-rich)],"All the variants had one PQS with the same score
",0,0,No PQS found in G4 Hunter,,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
CEBPA-AS1,oral squamous cell carcinoma,"Microarray, qPCR, Western blot, in vitro knockdown etc.",up-regulated,29281558.0,Also known as: ADINR; CEBPA-AS1,1,NR_026887.2,,26,5,1,VALIDATED,,,,,,,,ADINR; CEBPA-AS1
CRNDE,tongue squamous cell carcinoma,"qPCR, Western blot, other",up-regulated,30242873.0,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5,7,5,7,7","0,2,0,2,2","0,0,0,0,0",VALIDATED,"0;

5 (2 - C-rich, 3 - 3G);

0;

5 (2 - C-rich, 3 - 3G);

5 (2 - C-rich, 3 - 3G)","0;

[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657 (3G)];

0;

[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657 (3G)]; 

[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657 (3G)] ","The PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have the same G tracts with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0;

0;

0;

0;

0","0;

0;

0;

0;

0",No PQS found in G4 Hunter,,CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180
DANCR,nasopharyngeal cancer,qPCR,up-regulated,30849642.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3 - C-rich);

1 (C-rich);

1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62 (C-rich)];

[-0.62 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"1 (C-rich);

1 (C-rich);

1 (C-rich)","[-1.444 (C-rich)];

[-1.444 (C-rich)];

[-1.444 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DANCR,nasopharyngeal cancer,"qPCR, Western blot",up-regulated,30720067.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3 - C-rich);

1 (C-rich);

1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62 (C-rich)];

[-0.62 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"1 (C-rich);

1 (C-rich);

1 (C-rich)","[-1.444 (C-rich)];

[-1.444 (C-rich)];

[-1.444 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DANCR,tongue squamous cell carcinoma,"qRT-PCR, Luciferase reporter assay, Western blot",up-regulated,31827393.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3 - C-rich);

1 (C-rich);

1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62 (C-rich)];

[-0.62 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"1 (C-rich);

1 (C-rich);

1 (C-rich)","[-1.444 (C-rich)];

[-1.444 (C-rich)];

[-1.444 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DANCR,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown, RIP, etc.",up-regulated,30555573.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3 - C-rich);

1 (C-rich);

1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62 (C-rich)];

[-0.62 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"1 (C-rich);

1 (C-rich);

1 (C-rich)","[-1.444 (C-rich)];

[-1.444 (C-rich)];

[-1.444 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DGCR5,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, RIP",up-regulated,30980388.0,"Also Known As: DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037

2 sequences for DGCR5 (NR_026651.1, NR_024159.1) without any mentioning of transcript variants, while 3 sequences of DGCR5 with clear mentioning of transcipt variants.

PREDICTED REFSEQ (NR_026651.1): This record has not been reviewed and the function is unknown. The reference sequence was derived from BU584104.1, AC000095.5, L77559.1 and BM681417.1.

All transcriprt variants of DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1, NR_026651.1 and NR_024159.1) are reported (Gene Cards - GCID: GC22P019556)

PQS 2 obtained in DGCR5_Variant 2 (NR_045121.1) when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3. Rest two PQS were same in both search parameters.
For further consideration, PQS when search parameter was set to Min G-Group Size: 3 was taken.","3 (DGCR5)
+
2 (DGCR5 unknown variants)
=5","DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1)
+
DGCR5 unknown variants (NR_026651.1, NR_024159.1)","32, 32, 11 (DGCR5)
+
7, 28 (DGCR5 unknown variants)","29,29,11,5,25","3,3,0,2,3","0,0,0,0,0","VALIDATED (DGCR5)

PREDICTED (DGCR5 unknown variant-NR_026651.1)

VALIDATED (DGCR5 unknown variant-NR_024159.1)
","12 (4 - C-rich, 8 - 2G);

12 (4 - C-rich, 8 - 2G);

5 (4 - C-rich, 1 - 2G)","[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[0.911 (2G), -0.894, -0.854, -0.902, -0.933 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037
DGCR5,laryngeal cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,30549038.0,"Also Known As: DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037

2 sequences for DGCR5 (NR_026651.1, NR_024159.1) without any mentioning of transcript variants, while 3 sequences of DGCR5 with clear mentioning of transcipt variants.

PREDICTED REFSEQ (NR_026651.1): This record has not been reviewed and the function is unknown. The reference sequence was derived from BU584104.1, AC000095.5, L77559.1 and BM681417.1.

All transcriprt variants of DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1, NR_026651.1 and NR_024159.1) are reported (Gene Cards - GCID: GC22P019556)

PQS 2 obtained in DGCR5_Variant 2 (NR_045121.1) when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3. Rest two PQS were same in both search parameters.
For further consideration, PQS when search parameter was set to Min G-Group Size: 3 was taken.","3 (DGCR5)
+
2 (DGCR5 unknown variants)
=5","DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1)
+
DGCR5 unknown variants (NR_026651.1, NR_024159.1)","32, 32, 11 (DGCR5)
+
7, 28 (DGCR5 unknown variants)","29,29,11,5,25","3,3,0,2,3","0,0,0,0,0","VALIDATED (DGCR5)

PREDICTED (DGCR5 unknown variant-NR_026651.1)

VALIDATED (DGCR5 unknown variant-NR_024159.1)
","12 (4 - C-rich, 8 - 2G);

12 (4 - C-rich, 8 - 2G);

5 (4 - C-rich, 1 - 2G)","[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[0.911 (2G), -0.894, -0.854, -0.902, -0.933 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037
DLEU1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc",up-regulated,32214823.0,"Also Known As: BCMS; DLB1; LEU1; LEU2; XTP6; BCMS1; DLEU2; LINC00021; NCRNA00021

Some (not checked for PQS) DLEU1-AS1 ""lncRNA"" ncRNA (NR_125753.1) was also there in result.",3,"NR_109973.1, NR_002605.2, NR_109974.1","10,9,8","10,9,8","0,0,0","0,0,0",VALIDATED,"2 (1 - 2G, 1 - C-rich);

2 (1 - 2G, 1 - C-rich);

2 (2G)","[0.774 (2G), -0.804 (C-rich)];

[0.774 (2G), -0.804 (C-rich)]; 

[0.744, 1 (2G)] ",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,BCMS; DLB1; LEU1; LEU2; XTP6; BCMS1; DLEU2; LINC00021; NCRNA00021
DLEU1,oral squamous cell carcinoma,"Microarray, qPCR, Western blot",up-regulated,30069008.0,"Also Known As: BCMS; DLB1; LEU1; LEU2; XTP6; BCMS1; DLEU2; LINC00021; NCRNA00021

Some (not checked for PQS) DLEU1-AS1 ""lncRNA"" ncRNA (NR_125753.1) was also there in result.",3,"NR_109973.1, NR_002605.2, NR_109974.1","10,9,8","10,9,8","0,0,0","0,0,0",VALIDATED,"2 (1 - 2G, 1 - C-rich);

2 (1 - 2G, 1 - C-rich);

2 (2G)","[0.774 (2G), -0.804 (C-rich)];

[0.774 (2G), -0.804 (C-rich)]; 

[0.744, 1 (2G)] ",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,BCMS; DLB1; LEU1; LEU2; XTP6; BCMS1; DLEU2; LINC00021; NCRNA00021
DLEU2,laryngeal cancer,"qPCR, Luciferase reporter assay, in vitro knockdown etc.",down-regulated,29687850.0,"Also Known As: ALT1; DLB2; LEU2; RFP2; 
BCMSUN; RFP2OS; MIR15AHG; TRIM13OS; 
LINC00022; NCRNA00022

DLEU2 is another name for DLEU1 but not the other way around.",7,"NR_152566.1, NR_152567.1,
NR_152568.1, NR_152569.1,
NR_152571.1, NR_152570.1,
NR_152572.1

","20,2,2,2,8,2,8","18,2,2,2,8,2,8","1,0,0,0,0,0,0","1,0,0,0,0,0,0",REVIEWED,"2 (1 - 2G, 1 - C-rich);

2 (1 - 2G, 1 - C-rich);

2 (2G)","[0.774 (2G), -0.804 (C-rich)];

[0.774 (2G), -0.804 (C-rich)]; 

[0.744, 1 (2G)] ",No similarity to any PQS (2G)  from QGRS mapper,"0;

0;

0","0;

0;

0",No PQS found in G4 Hunter,,ALT1; DLB2; LEU2; RFP2; BCMSUN; RFP2OS; MIR15AHG; TRIM13OS; LINC00022; NCRNA00022
DLX6-AS1,laryngeal cancer,"qPCR, Western blot etc.",up-regulated,32368147.0,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),[0.854 (2G)],No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,Evf-2; DLX6AS; DLX6-AS; NCRNA00212
DLX6-AS1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc",up-regulated,31782911.0,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),[0.854 (2G)],No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,Evf-2; DLX6AS; DLX6-AS; NCRNA00212
DLX6-AS1,laryngeal squamous cell cancer,qRT-PCR,up-regulated,31814904.0,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),[0.854 (2G)],No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,,Evf-2; DLX6AS; DLX6-AS; NCRNA00212
DRAIC,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,31497998.0,,1,NR_026979.1,10,10,0,0,VALIDATED,3 (C-rich),"[-0.796, -0.873, -0.907 (C-rich)]
","No similarity to PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,,"downregulated RNA in cancer, inhibitor of cell invasion and migration;downregulated RNA in androgen independent cells;lnc-RPLP1-12;HSALNG0106873;HSALNG0106861;HSALNG0106864;HSALNG0106856;NONHSAG017288.2;NONHSAG017290.2;HSALNG0106871;NONHSAG017294.2;HSALNG0106875;HSALNG0106878;HSALNG0106865"
DUXAP8,oral cancer,"qPCR, RIP etc.",up-regulated,32304409.0,"""Homo sapiens double homeobox A pseudogene 8 (DUXAP8), non-coding RNA

transcribed RNA-misc_RNA (mentioned as lncRNA in title of papers; PubMed - 30367681, 30317248 and others)

Gene type - pseudo""",1,NR_122113.1,,11,0,0,VALIDATED,,,,,,,,double homeobox A pseudogene 8
ELF3-AS1,oral squamous cell carcinoma,"RT-qPCR, Western blot",up-regulated,31686842.0,Also Known As: SCAT7,1,NR_146472.1,8,6,2,0,VALIDATED,2 (3G),"[0.969, 0.721 (3G)] ","PQS 1 (3G) of QGRS mapper and PQS 1 (3G) of G4 hunter have the same G tracts.

PQS 3 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.",0,0,No PQS found in G4 Hunter,,SCAT7
EPB41L4A-AS2,head and neck squamous cell carcinoma,"RNA-seq, Microarray, qPCR, Western blot",down-regulated,29490660.0,Also Known As: EPB41L4A-AS2,1,NR_027706.1,17,15,2,0,VALIDATED,"10 (4 - 2G, 4 - 3G, 2 - C-rich)
","[-0.933, -0.684 (C-rich), 0.875, 0.911, 0.891, 0.911 (2G), 0.772, 0.911, 0.784, 0.839 (3G)]","PQS 6 (3G) of QGRS mapper and PQS 7 (3G) of G4 hunter have the same G tracts.

PQS 10 (3G) of QGRS mapper and PQS 8 (3G) of G4 hunter have the same G tracts.",1 (3G),[1.231 (3G)],"PQS 10 (3G) of QGRS mapper and PQS 1 (3G) of G4 hunter have the same G tracts.
",,EPB41L4A-AS2
EWSAT1,nasopharyngeal cancer,"qPCR, Western blot",up-regulated,29966979.0,Also Known As: TMEM84; LINC00277; NCRNA00277,1,NR_026949.1,15,14,1,0,VALIDATED,"17 (2 - 2G, 2 - 3G, 13 - C-rich)","[0.894, 0.911 (2G), 0.894, 0.813 (3G), -0.913, -1, -0.854, -0.646, -0.894, -0.915, -0.911, -0.984, -0.93, -0.891, -0.979, -0.894. -0.933 (C-rich)] ","PQS 13 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

By looking at  PQS 2 and 3 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.",0,0,No PQS found in G4 Hunter,,TMEM84; LINC00277; NCRNA00277
EWSAT1,nasopharyngeal cancer,"qPCR, Cell transfection, Western blot, Luciferase reporter assay, RNA pull-down assay etc.",up-regulated,27816050.0,Also Known As: TMEM84; LINC00277; NCRNA00277,1,NR_026949.1,15,14,1,0,VALIDATED,"17 (2 - 2G, 2 - 3G, 13 - C-rich)","[0.894, 0.911 (2G), 0.894, 0.813 (3G), -0.913, -1, -0.854, -0.646, -0.894, -0.915, -0.911, -0.984, -0.93, -0.891, -0.979, -0.894. -0.933 (C-rich)] ","PQS 13 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

By looking at  PQS 2 and 3 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.",0,0,No PQS found in G4 Hunter,,TMEM84; LINC00277; NCRNA00277
FAL1,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,31298329.0,Also Known As: FALEC; FAL1; ncRNA-a1; LINC00568,1,NR_051960.1,8,8,0,0,VALIDATED,"3 (2 - 2G, 1 - C-rich)","[0.88, 0.851 (2G), -0.921 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,,FAL1; ncRNA-a1; LINC00568
FALEC,Tongue squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, RIP",down-regulated,31335317.0,Also Known As: FAL1; ncRNA-a1; LINC00568,1,NR_051960.1,8,8,0,0,VALIDATED,"3 (2 - 2G, 1 - C-rich)","[0.88, 0.851 (2G), -0.921 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,,FAL1; ncRNA-a1; LINC00568
FAM225A,nasopharyngeal cancer,"Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,31331909.0,"Also Known As: C9orf109; LINC00256A; 
NCRNA00256A",1,NR_024366.1,64,56,7,1,VALIDATED,"19 (3 - 2G, 9 - 3G, 7 - C-rich)","[0.911, 0.733, 0.911 (2G), 0.82, 0.755, 0.788, 0.538, 0.91, 0.911, 0.942, 0.88, 0.958 (3G), -0.902, -0.84, -0.926, -0.979, -0.911, -0.939, -0.891 (C-rich)]","PQS 16 (3G) of QGRS mapper and PQS 6 (3G) of G4 hunter have the same G tracts.

PQS 23 (3G) of QGRS mapper and PQS 8 (3G) of G4 hunter have the same G tracts.

PQS 23 (3G) of QGRS mapper and PQS 9 (3G) of G4 hunter have the same G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 23 (3G) from QGRS mapper.

PQS 32 (3G) of QGRS mapper and PQS 10 (3G) of G4 hunter have the same G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 32 (3G) from QGRS mapper.

PQS 37 (3G) of QGRS mapper and PQS 11 (3G) of G4 hunter have the same G tracts.

PQS 42 (3G) of QGRS mapper and PQS 14 (3G) of G4 hunter have the same G tracts.

PQS 52 (3G) of QGRS mapper and PQS 16 (3G) of G4 hunter have the same G tracts.

By looking at  PQS 8 and 9 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.","3 (2 - 3G, 1 - 4G)","[1.218, 1.4 (3G), 1.528 (4G)] ","PQS 37 (3G) of QGRS mapper and PQS 1 (3G) of G4 hunter have the same G tracts.

PQS 37 (4G) of QGRS mapper and PQS 2 (4G) of G4 hunter have the same G tracts.

PQS 52 (3G) of QGRS mapper and PQS 3 (3G) of G4 hunter have the same G tracts.",,C9orf109; LINC00256A; NCRNA00256A
FAM87A,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,,1,NR_103537.1,37,36,1,0,VALIDATED,"1 (3 - 2G, 2 - 3G, 2 - C-rich)
","[0.989, 0.851 (3G), 0.913, 0.911, 0.891 (2G), -0.776, -0.911 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,2 (3G),"[1.444, 1.46 (3G)] ","PQS 6 (3G) of QGRS mapper and PQS 1 (3G) of G4 hunter have the same G tracts.

PQS 6 (3G) of QGRS mapper and PQS 2 (3G) of G4 hunter have the same G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 6 (3G) from QGRS mapper.

By looking at  PQS 1 and 2 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.",,"family with sequence similarity 87 member A;family with sequence similarity 87, member A;HSALNG0062877;FAM87A;NONHSAG049338.2;Protein FAM87A"
FEZF1-AS1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,30355645.0,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6 - 2G, 5 - C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G), 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,,FEZF1 antisense RNA 1;FEZF1 antisense RNA 1 (non-protein coding);HSALNG0060982;FEZF1-AS1;NONHSAG048666.2
FEZF1-AS1,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay",up-regulated,31378890.0,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6 - 2G, 5 - C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G), 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,,FEZF1 antisense RNA 1;FEZF1 antisense RNA 1 (non-protein coding);HSALNG0060982;FEZF1-AS1;NONHSAG048666.2
FGD5-AS1,oral squamous cell carcinoma,"qRT-PCR, Western blot, Luciferase Reporter Assay",up-regulated,31899825.0,,5,"NR_046251.1, NR_046252.1, NR_046253.1, NR_046254.1, NR_046255.1","18, 21, 20, 20, 17","17,21,20,20,15","1,0,0,0,2","0,0,0,0,0",VALIDATED,"10 (5 - G, 5 - C-rich);

3 (2 - 2G, 1 - C-rich);

3 (2 - 2G, 1 - C-rich);

3 (2 - 2G, 1 - C-rich);

2 (1 - 3G, 1 - C-rich)","[-0.738, -0.911, -0.911, -0.466, -0.911 (C-rich), 0.825, 1.16 (2G), 0.647, 0.788, 0.956 (3G)];

[0.915, 0.933 (2G), -0.911 (C-rich)];

[0.915, 0.933 (2G), -0.911 (C-rich)];


[0.915, 0.933 (2G), -0.911 (C-rich)];

[0.831 (3G), -0.911 (C-rich)]","
In variant 1, PQS 5 (3G) of QGRS mapper and PQS 7 (3G) of G4 hunter have the same G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper.

PQS 5 (3G) of QGRS mapper and PQS 8 (3G) of G4 hunter have the same G tracts.

PQS 5 (3G) of QGRS mapper and PQS 8 (3G) of G4 hunter have the same G tracts.

By looking at PQS 7, 8 and 9 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

In variants 2, 3 and 4, no similarity to any PQS from QGRS mapper is found.

In variant 5, PQS 4 (3G) of QGRS mapper and PQS 1 (3G) of G4 hunter have the same G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,FGD5 antisense RNA 1;FGD5 antisense RNA 1 (non-protein coding);FGD5-AS1;NONHSAG034508.2;HSALNG0024364;HSALNG0024365;HSALNG0024362
FLJ22447,oral squamous cell carcinoma,"RNA-seq, qPCR, RIP",up-regulated,29346528.0,,1,NR_039985.1,4,4,0,0,VALIDATED,1 (2G),[0.651 (2G)],No similarity to PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,,uncharacterized LOC400221;HSALNG0101773
FOXCUT,oral squamous cell carcinoma,"qPCR, RNAi, Western blot etc.",up-regulated,24889262.0,Also Known As: LINC01379; TCONS_00011636,1,NR_125804.1,15,13,2,0,VALIDATED,"22 (3 - 2G, 3 - 3G, 16 - C-rich)","[0.833, 0.891, 0.911 (2G), 0.911, 0.766, 0.607 (3G), -0.652, -0.98, -0.936, -0.878, -0.87, -0.911, -0.983, -0.891, -0.745, -0.8, -0.92, -0.771, -1.073, -0.935, -0.84, -0.891 (C-rich)]","PQS 14 (3G) of QGRS mapper and PQS 21 (3G) of G4 hunter have the same G tracts.

PQS 14 (3G) of QGRS mapper and PQS 22 (3G) of G4 hunter have the same G tracts.

PQS 22 (3G) from G4 hunter has a left frame-shift as compared to PQS 14 (3G) from QGRS mapper.

By looking at PQS 21 and 22 (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed and have few common G-tracts due to overlap amongst them.",0,0,No PQS found in G4 Hunter,,LINC01379; TCONS_00011636
FOXD2-AS1,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown etc.",up-regulated,29248577.0,,1,NR_026878.1,24,21,3,0,VALIDATED,"10 (3 - 2G, 3 - 3G, 4 - C-rich)
","[0.891, 0.933, 0.833 (2G), 0.797, 0.98, 0.833 (3G), -0.639, -0.767, -0.907, -0.891 (C-rich)]","The PQS 1 (3G) of QGRS Mapper is similar to PQS 3 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence.
 
Similarly, the PQS 2 (3G) of QGRS Mapper is similar to PQS 5 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence. 
There is a slight overlap in PQS 5 and 6 (3G) of G4 hunter.",2 (C-rich),"[-1.264, -0.94 (C-rich)]
",No similarity to any PQS (2G) from QGRS mapper,,FOXD2 adjacent opposite strand RNA 1;MGC12982;FOXD2 antisense RNA 1 (non-protein coding);FOXD2 antisense RNA 1;FOXD2 antisense RNA 1 (head to head);HSALNG0003395;FOXD2-AS1;NONHSAG001375.2
FOXD3-AS1,nasopharyngeal cancer,"RT-qPCR, Western blot, Microarray",up-regulated,32073875.0,"Also Known As: pasFOXD3

Some (older-not checked for PQS) FOXD3 antisense RNA 1 ""antisense RNA"" ncRNA (complete sequence - KF925349.1) was also there in result.",4,"NR_121634.1, NR_121635.1, NR_121636.1, NR_121637.1","11, 7, 8, 8","11,6,8,8","0,1,0,0","0,0,0,0",VALIDATED,"8 (4 - 2G, 4 - C-rich);

4 (1 - 2G, 3 - C-rich);

3 (1 - 2G, 2 - C-rich);

3 (1 - 2G, 2 - C-rich)","[-0.913, -0.776, -0.86, -0.917 (C-rich), 0.911, 0.872, 0.8, 0.979 (2G)];

[-0.913, -0.86, -0.917 (C-rich),  0.979 (2G)];

[0.979 (2G), -0.86, -0.917 (C-rich)];

[0.979 (2G), -0.86, -0.917 (C-rich)]","No similarity to PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,,FAST; pasFOXD3
FRMD6-AS1,nasopharyngeal cancer,"Microarray, qPCR etc.",up-regulated,27886062.0,Also Known As: C14orf82,1,NR_037676.1,23,23,0,0,VALIDATED,"12 (6 - 2G, 6 - C-rich)","[-0.911, -0.64, -0.821, -0.906, -0.854, -0.765 (C-rich), 0.776, 0.814, 0.857, 0.911, 0.933, 0.854 (2G)]","No similarity to PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,,C14orf82
GAS5,oral squamous cell carcinoma,"qRT-PCR , Luciferase reporter assay , RNAi , in vitro knockdown etc.",up-regulated,31583913.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5,6,5,5,5,5,5,3,4,3,5,5,5,5,5","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,SNHG2; NCRNA00030
GAS5,laryngeal squamous cell cancer,"qRT-PCR, Western blotting etc.",down-regulated,31572003.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5,6,5,5,5,5,5,3,4,3,5,5,5,5,5","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,SNHG2; NCRNA00030
GAS5,oral squamous cell carcinoma,"qPCR, Western blot, etc.",down-regulated,30576678.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5,6,5,5,5,5,5,3,4,3,5,5,5,5,5","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,SNHG2; NCRNA00030
GAS5,head and neck cancer,qPCR etc.,down-regulated,26482616.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5,6,5,5,5,5,5,3,4,3,5,5,5,5,5","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,SNHG2; NCRNA00030
GAS5,nasopharyngeal cancer,"DNA Extraction and genotyping, SNPs selections etc.",differential expression,28977945.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5,6,5,5,5,5,5,3,4,3,5,5,5,5,5","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,SNHG2; NCRNA00030
GHET1,head and neck cancer,qPCR etc.,up-regulated,29725422.0,Also Known As: ncRNA-GHET1,1,NR_130107.1,10,9,1,0,REVIEWED,"5 (3-C-rich, 1-2G, 1-3G)
","['-0.911, -0.79, -0.959 (C-rich); 0.891, 0.644 (2G); 0.973 (3G)]",The PQS 10 (3G) of QGRS Mapper is similar to PQS 6 (3G) of G4 hunter with a left frame shift in G4 hunter,1 (3G),[1.413 (3G)],The PQS 10 (3G) of QGRS Mapper is similar to PQS 1 (3G) of G4 hunter with the same main G4 tracts.,,lncRNA-GHET1
GIHCG,tongue squamous cell carcinoma,qPCR,up-regulated,29953645.0,,1,NR_038269.1,4,4,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,"GIHCG inhibitor of miR-200b/200a/429 expression;lncRNA-GIHCG;lncRNA gradually increased during hepatocarcinogenesis;GIHCG, inhibitor of miR-200b/200a/429 expression;HSALNG0091676;lnc-CTDSP2-2;NONHSAG011461.2"
GNAS-AS1,nasopharyngeal cancer,"qPCR, Western blot etc",up-regulated,32271425.0,Also known as: SANG; GNASAS; NESPAS; GNAS-AS; GNAS1AS; NESP-AS; NCRNA00075,1,NR_002785.2,13,10,3,0,REVIEWED,"9 (4 - 2G, 2 - 3G, 3 - C-rich)","[0.805, 0.889 (3G), 0.911, 0.917, 0.933, 0.911 (2G), -1, -0.933, -0.955 (C-rich)]","PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. 

PQS 5 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.",1 (3G),[1.22 (3G)],"PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.",,SANG; GNASAS; NESPAS; GNAS-AS; GNAS1AS; NESP-AS; NCRNA00075
H19,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay",differential expression,29844862.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, Western blot",up-regulated,31556327.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29344674.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,nasopharyngeal cancer,"qPCR, Western blot, RIP etc.",up-regulated,27040767.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,laryngeal squamous cell cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,26872375.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,tongue squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29523225.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,head and neck squamous cell carcinoma,qPCR etc.,down-regulated,11592232.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,head and neck squamous cell carcinoma,qPCR etc.,differential expression,10597307.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,nasopharyngeal cancer,"qPCR, Northern blot, ISH etc.",up-regulated,12569573.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,head and neck squamous cell carcinoma,"qPCR, Cell transfection, Cell proliferation assay, Cell migration and invasion assay etc.",up-regulated,27994496.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 Hunter.",,ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
HAGLROS,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31334669.0,,1,NR_110457.1,6,6,0,0,VALIDATED,2 (C-rich),"[-0.957, -0.933 
(C-rich)]","
No similarity to PQS (2G) from QGRS mapper.
",2 (C-rich),"[-1.463, 
-1.422 (C-rich)]","No similarity to PQS (2G) from QGRS mapper.
",,HAGLR opposite strand lncRNA;HAGLR opposite strand (non-protein coding);HAGLROS;HSALNG0020595;NONHSAG029907.2
HAS2-AS1,oral squamous cell carcinoma,"Microarray, qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,28485478.0,Also known as: HASNT; HAS2AS; HAS2-AS; NCRNA00077,1,NR_002835.2,15,14,1,0,VALIDATED,"11 (1 - 2G, 1 - 3G, 9 - C-rich)
","[0.767 (3G), 0.824 (2G), -0.742, -0.869, -0.891, -0.837, -1, -0.947, -0.891, -0.913, -0.846 (C-rich)]
","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. ",3 (C-rich),"[-1.389, -1.404, 
-1.31 (C-rich)]","No similarity to PQS (2G) from QGRS mapper.
",,HASNT; HAS2AS; HAS2-AS; NCRNA00077
HCG11,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc",down-regulated,32271435.0,"Also Known As: CTA-14H9.3, bK14H9.3",1,NR_026790.1,35,31,4,0,VALIDATED,"6 (2 - 2G, 2 - 3G, 2 - C-rich)
","[0.904, 0.833, (3G), -0.754, -0.911 (C-rich), 0.648, 0.778  (2G)]","PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) from G4 hunter has a right frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",2 (3G),"[1.236, 1.319 (3G)]","PQS 29 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 29 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",,bK14H9.3; CTA-14H9.3
HCG18,nasopharyngeal cancer,"RT-PCR, Western blot, Luciferase Reporter Assays",up-regulated,31841193.0,,4,"NR_024052.2, NR_024053.2,
NR_102326.1, NR_102327.1","46,45,56,30","39,38,48,24","7,7,8,6","0,0,0,0",VALIDATED,"19 (9 - 2G, 6 - 3G, 4 - C-rich);

19 (9 - 2G, 6 - 3G, 4 - C-rich);

26 (19 - 2G; 7 - C-rich)

17 (8 - 2G; 6 - 3G, 3 - C-rich)","[0.857, 0.942, 0.94, 0.917, 1.019, 0.875 (3G), 0.792, 0.851, 0.938, 0.544, 0.87, 0.911, 0.935, 0.719, 0.935 (2G), -0.869, -0.912, -1.02, -0.717 (C-rich)];

[0.857, 0.942, 0.94, 0.917, 1.019, 0.875 (3G), 0.792, 0.851, 0.938, 0.544, 0.87, 0.911, 0.935, 0.719, 0.935 (2G), -0.869, -0.912, -1.02, -0.717 (C-rich)];

[0.857, 0.942, 0.94, 0.917, 0.899, 1.019, 0.875 (3G), 0.792, 0.851, 0.938, 0.544, 0.87, 0.911, 0.935, 0.896, 0.911, 0.911, 0.719, 0.935 (2G), -0.869, -0.87, -0.726, -1, -0.912, -1.02, -0.717 (C-rich)];

[0.857, 0.942, 0.94, 0.917, 1.019, 0.875 (3G), 0.792, 0.851, 0.938, 0.544, 0.87, 0.911, 0.935, 0.935 (2G), -0.869, -1.02, -0.717 (C-rich)]","In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 3 (3G) from QGRS mapper. 

In variant 1 and 2, PQS 9 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 35 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 39 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a right frame-shift as compared to PQS 39 (3G) from QGRS mapper.

In variant 3, PQS 9 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 8 (3G) from G4 hunter has a left frame-shift as compared to PQS 9 (3G) from QGRS mapper.

In variant 3, PQS 45 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

In variant 3, PQS 49 (3G) of QGRS mapper and the PQS 26 (3G) of G4 hunter have similar G tracts.

In variant 4, PQS 3 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 3 (3G) from QGRS mapper.

In variant 4, PQS 9 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

In variant 4, PQS 19 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

In variant 4, PQS 23 (3G) of QGRS mapper and the PQS 17 (3G) of G4 hunter have similar G tracts.

By looking at PQS 7 and 8 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.  ","1 (C-rich);

1 (C-rich);

1 (C-rich);

1 (C-rich);","(-1.203)

(-1.203)

(-1.203)

(-1.203)","No similarity to PQS (2G) from QGRS mapper.
",,HLA complex group 18;FLJ31598;FLJ25550;Em:AB014087.1;HLA complex group 18 (non-protein coding);HSALNG0049132;NONHSAG046574.2;lnc-TRIM26-2;NONHSAG045872.2;NONHSAG043403.2;NONHSAG045570.2;NONHSAG046390.2;NONHSAG045682.2;NONHSAG046057.2
HCG22,oral squamous cell carcinoma,qPCR,differential expression,28415559.0,"Also known as: PBMUCL2, Panbronchiolitis-Related Mucin-Like Protein, HLA Complex Group 22 (Non-Protein Coding)",2,"NR_003948.3, NR_145427.2",,"14,11","0,0","0,0",VALIDATED,,,,,,,,PBMUCL2
HCP5,oral squamous cell carcinoma,"RT-qPCR, Western blot analysis, Dual Luciferase Reporter Assay",up-regulated,31849534.0,Also Known As: P5-1; 6S2650E; D6S2650E,1,NR_040662.1,23,21,2,0,VALIDATED,"2 (1 - 3G, 1 - C-rich)","[0.913 (3G), -0.857 (C-rich)]","
PQS 18 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,P5-1; 6S2650E; D6S2650E
HNF1A-AS1,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,30404566.0,Also Known As: 5'aHIF-1A; 5'aHIF1alpha,1,NR_047116.1,4,4,0,0,VALIDATED,4 (C-rich);,"[-0.933, -0.808, -0.911, -0.792 (C-rich)]","
No similarity to PQS (2G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,5'aHIF-1A; 5'aHIF1alpha
HOTAIR,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,31995261.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal cancer,"RT-qPCR, Western blot analysis, Dual Luciferase Reporter Gene Assay, RIP",up-regulated,31849488.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal squamous cell cancer,"qRT-PCR , Western blot etc.",up-regulated,31171714.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,30053324.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, other",up-regulated,30314699.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31297902.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal squamous cell cancer,"qPCR, Western blot etc.",up-regulated,25099764.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,head and neck squamous cell carcinoma,"Microarray, qPCR etc.",differential expression,28159935.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,nasopharyngeal cancer,"qPCR, Western blotting etc.",up-regulated,29228426.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,nasopharyngeal cancer,"qPCR, RNAi, Western blot, Luciferase reporter assay, Flow cytometry assay etc.",up-regulated,26717040.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,nasopharyngeal cancer,"qPCR, ISH etc.",up-regulated,23281836.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,oral squamous cell carcinoma,"qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc.",up-regulated,27904675.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,oral squamous cell carcinoma,"qPCR, RNAi, MTT assay etc.",up-regulated,26036760.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,head and neck squamous cell carcinoma,"qPCR, Western blot, Flow cytometry assay etc.",differential expression,26592246.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal squamous cell cancer,qPCR etc.,up-regulated,25257554.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal squamous cell cancer,"qPCR, in vitro knockdown etc.",up-regulated,23141928.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,oral squamous cell carcinoma,qPCR etc.,up-regulated,23292713.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,head and neck squamous cell carcinoma,"qPCR, RNAi, Western blot, RIP, Luciferase reporter assay, Cell migration and invasion assay etc.",up-regulated,27941336.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,head and neck squamous cell carcinoma,"in vitro knockdown, Luciferase reporter assay, qPCR, Western blot, RNA-seq etc.",up-regulated,29540490.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,laryngeal squamous cell cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27542077.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,oral squamous cell carcinoma,"qPCR, RNAi, Western blot etc.",up-regulated,25901533.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16,","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,0,0,"No PQS found in G4 Hunter

",,HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIRM1,head and neck cancer,"qPCR, Western blot, Luciferase reporter assay",down-regulated,29905017.0,"Also Known As: HOXA-AS1; HOXA1-AS1; NCRNA00179

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIRM1 (HOTAIRM1 gene) and; HOXA cluster antisense intergenic RNA myeloid 1 antisense RNA (HOTAIRM1); ""antisense RNA"" ncRNA (TPA: HG975399.1; complete sequence-GQ479958.1 respectively) were also there in result.",2,"NR_038366.1, NR_038367.1","7, 5","6,4","1,1","0,0",REVIEWED,"5 (1 - 2G, 1 - 3G, 3 - C-rich);

4 (1 - 3G, 3 - C-rich)","[-0.872, -0.956, -0.569 (C-rich), 0.646 (2G), 0.735 (3G)];

[-0.872, -0.956, -0.569 (C-rich), 0.735 (3G)]","In variant 1, PQS 6 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 5 (3G) from G4 hunter has a left frame-shift as compared to PQS 6 (3G) from QGRS mapper.

In variant 2, PQS 4 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.","2 (1 - 3G, 1 - C-rich);

2 (1 - 3G, 1 - C-rich)","[-1.265 (C-rich), 1.179 (3G)];

[-1.265 (C-rich), 1.179 (3G)];","In variant 1 and 2, PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.",,HOXA-AS1; HOXA1-AS1; NCRNA00179
HOTAIRM1,head and neck cancer,"qPCR, Western blot, etc.",down-regulated,29905017.0,"Also Known As: HOXA-AS1; HOXA1-AS1; NCRNA00179

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIRM1 (HOTAIRM1 gene) and; HOXA cluster antisense intergenic RNA myeloid 1 antisense RNA (HOTAIRM1); ""antisense RNA"" ncRNA (TPA: HG975399.1; complete sequence-GQ479958.1 respectively) were also there in result.",2,"NR_038366.1, NR_038367.1","7, 5","6,4","1,1","0,0",REVIEWED,"5 (1 - 2G, 1 - 3G, 3 - C-rich);

4 (1 - 3G, 3 - C-rich)","[-0.872, -0.956, -0.569 (C-rich), 0.646 (2G), 0.735 (3G)];

[-0.872, -0.956, -0.569 (C-rich), 0.735 (3G)]","In variant 1, PQS 6 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 5 (3G) from G4 hunter has a left frame-shift as compared to PQS 6 (3G) from QGRS mapper.

In variant 2, PQS 4 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.","2 (1 - 3G, 1 - C-rich);

2 (1 - 3G, 1 - C-rich)","[-1.265 (C-rich), 1.179 (3G)];

[-1.265 (C-rich), 1.179 (3G)];","In variant 1 and 2, PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.",,HOXA-AS1; HOXA1-AS1; NCRNA00179
HOTTIP,oral tongue squamous cell carcinoma,"qRT-PCR, Dual luciferase reporter assay, Western blot assay",up-regulated,31910357.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,head and neck squamous cell carcinoma,qRT-PCR etc.,up-regulated,31032351.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30685769.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay",down-regulated,31328440.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,tongue squamous cell carcinoma,qPCR etc.,up-regulated,26058875.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]",No similarity to PQS (2G) from QGRS mapper.,,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOXA11-AS,hypopharyngeal squamous cell carcinoma,qRT-PCR,up-regulated,31987067.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 Hunter,,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HOXA11-AS,oral squamous cell carcinoma,"qRT-PCR, Western blot, RIP",up-regulated,31731187.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 Hunter,,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HOXA11-AS,oral squamous cell carcinoma,"qRT-PCR, Western blot analysis etc.",up-regulated,31139017.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 Hunter,,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HOXA11-AS,Oral Squamous Cell Carcinoma,"qPCR, Luciferase reporter assay",up-regulated,31275988.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 Hunter,,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HOXA11-AS,laryngeal squamous cell cancer,"Microarray, qPCR, in vitro knockdown",up-regulated,29511452.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 Hunter,,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HULC,oral squamous cell carcinoma,"qPCR, Western blot, RNAi, other",up-regulated,30419657.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,HCCAT1; LINC00078; NCRNA00078
HULC,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30677131.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,HCCAT1; LINC00078; NCRNA00078
HULC,nasopharyngeal cancer,"qPCR, Western blot etc.",up-regulated,28445086.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,HCCAT1; LINC00078; NCRNA00078
INHBA-AS1,oral squamous cell carcinoma,RT-qPCR,up-regulated,32141551.0,,2,"NR_027118.2, NR_027119.2","21,7","20,7","1,0","0,0",VALIDATED,"2 (1 - 3G, 1 - C-rich);

0","[0.798 (3G), -0.69 (C-rich)];

0","In variant 1, PQS 6 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 6 (3G) from QGRS mapper.","1 (C-rich);

0","[-1.4 (C-rich)]

0","No similarity to PQS (2G) from QGRS mapper.
",,INHBA antisense RNA 1;INHBA antisense RNA 1 (non-protein coding);INHBA-AS1;NONHSAG047432.2;HSALNG0057479;NONHSAG047433.2
KCNQ1OT1,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,31755091.0,"Also Known As: LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012

Some (older-not checked for PQS) Long non-coding sense-intronic RNA Kcnq1ot1 (Kncq1 gene) ""lncRNA"" ncRNA (TPA: HG975405.1) was also there in result.",1,NR_002728.3,581,538,41,2,REVIEWED,"185 (59 - 2G, 32 - 3G, 3 - 4G, 91 - C-rich)","[0.914, 0.978, 1.23 (4G) 0.938, 0.942, 1.021, 0.911, 0.94, 1.008,  0.941, 0.627, 0.911, 0.765, 0.904, 0.691, 1.043, 0.886, 1.086, 0.911, 0.821, 0.957, 0.9, 0.852, 0.85, 0.73, 0.944, 0.754, 0.891, 0.857, 0.979, 0.958, 0.936, 1.021, 0.867, 1.071 (3G), 0.872, 0.911, 0.891, 0.852, 0.879, 1.019, 0.911, 0.933, 0.891, 0.933, 0.804, 0.911, 0.9, 0.891, 0.933, 0.911, 0.911, 0.918, 0.979, 1, 0.811, 0.852, 0.875, 0.911, 0.891, 0.827, 0.978, 0.915, 0.808, 0.863, 0.745, 0.902, 1.021, 0.825,  0.894, 0.891, 0.878, 0.902, 0.911, 0.741, 0.965, 0.86, 0.935, 0.84, 0.638, 0.872, 0.875, 0.911, 0.891, 0.791, 0.811, 0.872, 0.933, 0.721, 0.854, 0.891, 0.957, 0.9, 0.828 (2G), -0.891, -0.875, -0.911, -0.933, -0.788, -0.882, -0.911, -0.824, -0.906, -1.086, -0.915, -0.87, -0.894, -0.861, -0.957, -0.718, -0.75, -0.826, -0.911, -0.911, -0.911, -0.733, -0.851, -0.773, -0.757, -1.021, -0.965, -0.911, -1.043, -0.894, -0.766, -0.87, -0.891, -0.942, -0.945, -0.891, -0.916, -0.872, -0.891, -1, -0.911,  -0.719, -0.882, -0.891, -0.917, -0.911, -1.022, -0.911, -0.911, -0.894, -0.698, -0.894, -1, -0.935, -0.943, -0.857,  -0.707, -0.911, -0.942, -0.827, -0.981, -0.959, -0.911, -0.933, -0.943, -0.8, -0.911, -0.911, -0.872, -0.93, -0.978, -0.956, -0.896, -0.933, -0.843, -0.915, -0.891, -0.911, -0.855, -0.671, -0.891, -0.677, -0.911, -0.956, -0.944, -1, -0.911, -0.957, -0.86, -0.872, -0.872 (C-rich)]","PQS 22 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 57 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

PQS 72 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 81 (3G) of QGRS mapper and the PQS 24 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) from G4 hunter has a left frame-shift as compared to PQS 81 (3G) from QGRS mapper.

PQS 103 (3G) of QGRS mapper and the PQS 31 (3G) of G4 hunter have similar G tracts.

PQS 116 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

PQS 41 (3G) from G4 hunter has a left frame-shift as compared to PQS 116 (3G) from QGRS mapper.

PQS 132 (3G) of QGRS mapper and the PQS 46 (3G) of G4 hunter have similar G tracts.

PQS 143 (3G) of QGRS mapper and the PQS 48 (3G) of G4 hunter have similar G tracts.

PQS 48 (3G) from G4 hunter has a left frame-shift as compared to PQS 143 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 65 (3G) of G4 hunter have similar G tracts.

PQS 65 (3G) from G4 hunter has a left frame-shift as compared to PQS 187 (3G) from QGRS mapper.

PQS 215 (3G) of QGRS mapper and the PQS 69 (3G) of G4 hunter have similar G tracts.

PQS 219 (3G) of QGRS mapper and the PQS 70 (3G) of G4 hunter have similar G tracts.

PQS 262 (3G) of QGRS mapper and the PQS 89 (3G) of G4 hunter have similar G tracts.

PQS 297 (3G) of QGRS mapper and the PQS 105 (3G) of G4 hunter have similar G tracts.

PQS 299 (3G) of QGRS mapper and the PQS 108 (3G) of G4 hunter have similar G tracts.

PQS 310 (3G) of QGRS mapper and the PQS 115 (3G) of G4 hunter have similar G tracts.

PQS 317 (3G) of QGRS mapper and the PQS 117 (3G) of G4 hunter have similar G tracts.

PQS 345 (4G) of QGRS mapper and the PQS 128 (4G) of G4 hunter have similar G tracts.

PQS 351 (3G) of QGRS mapper and the PQS 133 (3G) of G4 hunter have similar G tracts.

PQS 362 (3G) of QGRS mapper and the PQS 135 (3G) of G4 hunter have similar G tracts.

PQS 381 (3G) of QGRS mapper and the PQS 139 (3G) of G4 hunter have similar G tracts.

PQS 397 (3G) of QGRS mapper and the PQS 147 (3G) of G4 hunter have similar G tracts.

PQS 398 (3G) of QGRS mapper and the PQS 148 (3G) of G4 hunter have similar G tracts.

PQS 148 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 150 (3G) of G4 hunter have similar G tracts.

PQS 150 (3G) from G4 hunter has a left frame-shift as compared to PQS 400 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 151 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 171 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 185 (3G) of G4 hunter have similar G tracts.

PQS 185 (3G) from G4 hunter has a left frame-shift as compared to PQS 577 (3G) from QGRS mapper.

By looking at PQS 69 and 70 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",24 (  12 - C-rich)  ,"[-1.333, -1.396,, -1.053, -1.195, -1.354, -1.511, -1.4, -1.422, -1.286, -1.293, -1.17, -1.4 (C-rich), 1.404, 1.178, 1.333, 1.381, 1.114, 1.37, 1.314, 1.396 (3G), 1.042, 1.372 (4G), 1.4, 1.4 (2G)]","PQS 128 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 128 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 194 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 345 (3G) of QGRS mapper and the PQS 14 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) from G4 hunter has a left frame-shift as compared to PQS 345 (3G) from QGRS mapper.

PQS 381 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) from G4 hunter has a left frame-shift as compared to PQS 381 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 19 and 20 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",,LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012
KCNQ1OT1,tongue squamous cell carcinoma,"Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,29970910.0,"Also Known As: LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012

Some (older-not checked for PQS) Long non-coding sense-intronic RNA Kcnq1ot1 (Kncq1 gene) ""lncRNA"" ncRNA (TPA: HG975405.1) was also there in result.",1,NR_002728.3,581,538,41,2,REVIEWED,"185 (59 - 2G, 32 - 3G, 3 - 4G, 91 - C-rich)","[0.914, 0.978, 1.23 (4G) 0.938, 0.942, 1.021, 0.911, 0.94, 1.008,  0.941, 0.627, 0.911, 0.765, 0.904, 0.691, 1.043, 0.886, 1.086, 0.911, 0.821, 0.957, 0.9, 0.852, 0.85, 0.73, 0.944, 0.754, 0.891, 0.857, 0.979, 0.958, 0.936, 1.021, 0.867, 1.071 (3G), 0.872, 0.911, 0.891, 0.852, 0.879, 1.019, 0.911, 0.933, 0.891, 0.933, 0.804, 0.911, 0.9, 0.891, 0.933, 0.911, 0.911, 0.918, 0.979, 1, 0.811, 0.852, 0.875, 0.911, 0.891, 0.827, 0.978, 0.915, 0.808, 0.863, 0.745, 0.902, 1.021, 0.825,  0.894, 0.891, 0.878, 0.902, 0.911, 0.741, 0.965, 0.86, 0.935, 0.84, 0.638, 0.872, 0.875, 0.911, 0.891, 0.791, 0.811, 0.872, 0.933, 0.721, 0.854, 0.891, 0.957, 0.9, 0.828 (2G), -0.891, -0.875, -0.911, -0.933, -0.788, -0.882, -0.911, -0.824, -0.906, -1.086, -0.915, -0.87, -0.894, -0.861, -0.957, -0.718, -0.75, -0.826, -0.911, -0.911, -0.911, -0.733, -0.851, -0.773, -0.757, -1.021, -0.965, -0.911, -1.043, -0.894, -0.766, -0.87, -0.891, -0.942, -0.945, -0.891, -0.916, -0.872, -0.891, -1, -0.911,  -0.719, -0.882, -0.891, -0.917, -0.911, -1.022, -0.911, -0.911, -0.894, -0.698, -0.894, -1, -0.935, -0.943, -0.857,  -0.707, -0.911, -0.942, -0.827, -0.981, -0.959, -0.911, -0.933, -0.943, -0.8, -0.911, -0.911, -0.872, -0.93, -0.978, -0.956, -0.896, -0.933, -0.843, -0.915, -0.891, -0.911, -0.855, -0.671, -0.891, -0.677, -0.911, -0.956, -0.944, -1, -0.911, -0.957, -0.86, -0.872, -0.872 (C-rich)]","PQS 22 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 57 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

PQS 72 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 81 (3G) of QGRS mapper and the PQS 24 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) from G4 hunter has a left frame-shift as compared to PQS 81 (3G) from QGRS mapper.

PQS 103 (3G) of QGRS mapper and the PQS 31 (3G) of G4 hunter have similar G tracts.

PQS 116 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

PQS 41 (3G) from G4 hunter has a left frame-shift as compared to PQS 116 (3G) from QGRS mapper.

PQS 132 (3G) of QGRS mapper and the PQS 46 (3G) of G4 hunter have similar G tracts.

PQS 143 (3G) of QGRS mapper and the PQS 48 (3G) of G4 hunter have similar G tracts.

PQS 48 (3G) from G4 hunter has a left frame-shift as compared to PQS 143 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 65 (3G) of G4 hunter have similar G tracts.

PQS 65 (3G) from G4 hunter has a left frame-shift as compared to PQS 187 (3G) from QGRS mapper.

PQS 215 (3G) of QGRS mapper and the PQS 69 (3G) of G4 hunter have similar G tracts.

PQS 219 (3G) of QGRS mapper and the PQS 70 (3G) of G4 hunter have similar G tracts.

PQS 262 (3G) of QGRS mapper and the PQS 89 (3G) of G4 hunter have similar G tracts.

PQS 297 (3G) of QGRS mapper and the PQS 105 (3G) of G4 hunter have similar G tracts.

PQS 299 (3G) of QGRS mapper and the PQS 108 (3G) of G4 hunter have similar G tracts.

PQS 310 (3G) of QGRS mapper and the PQS 115 (3G) of G4 hunter have similar G tracts.

PQS 317 (3G) of QGRS mapper and the PQS 117 (3G) of G4 hunter have similar G tracts.

PQS 345 (4G) of QGRS mapper and the PQS 128 (4G) of G4 hunter have similar G tracts.

PQS 351 (3G) of QGRS mapper and the PQS 133 (3G) of G4 hunter have similar G tracts.

PQS 362 (3G) of QGRS mapper and the PQS 135 (3G) of G4 hunter have similar G tracts.

PQS 381 (3G) of QGRS mapper and the PQS 139 (3G) of G4 hunter have similar G tracts.

PQS 397 (3G) of QGRS mapper and the PQS 147 (3G) of G4 hunter have similar G tracts.

PQS 398 (3G) of QGRS mapper and the PQS 148 (3G) of G4 hunter have similar G tracts.

PQS 148 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 150 (3G) of G4 hunter have similar G tracts.

PQS 150 (3G) from G4 hunter has a left frame-shift as compared to PQS 400 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 151 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 171 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 185 (3G) of G4 hunter have similar G tracts.

PQS 185 (3G) from G4 hunter has a left frame-shift as compared to PQS 577 (3G) from QGRS mapper.

By looking at PQS 69 and 70 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",24 (  12 - C-rich)  ,"[-1.333, -1.396,, -1.053, -1.195, -1.354, -1.511, -1.4, -1.422, -1.286, -1.293, -1.17, -1.4 (C-rich), 1.404, 1.178, 1.333, 1.381, 1.114, 1.37, 1.314, 1.396 (3G), 1.042, 1.372 (4G), 1.4, 1.4 (2G)]","PQS 128 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 128 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 194 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 345 (3G) of QGRS mapper and the PQS 14 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) from G4 hunter has a left frame-shift as compared to PQS 345 (3G) from QGRS mapper.

PQS 381 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) from G4 hunter has a left frame-shift as compared to PQS 381 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 19 and 20 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",,LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012
KCNQ1OT1,tongue squamous cell carcinoma,"qRT-PCR, Western blot analysis, Dual Luciferase Reporter Assays, RIP",up-regulated,31957833.0,"Also Known As: LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012

Some (older-not checked for PQS) Long non-coding sense-intronic RNA Kcnq1ot1 (Kncq1 gene) ""lncRNA"" ncRNA (TPA: HG975405.1) was also there in result.",1,NR_002728.3,581,538,41,2,REVIEWED,"185 (59 - 2G, 32 - 3G, 3 - 4G, 91 - C-rich)","[0.914, 0.978, 1.23 (4G) 0.938, 0.942, 1.021, 0.911, 0.94, 1.008,  0.941, 0.627, 0.911, 0.765, 0.904, 0.691, 1.043, 0.886, 1.086, 0.911, 0.821, 0.957, 0.9, 0.852, 0.85, 0.73, 0.944, 0.754, 0.891, 0.857, 0.979, 0.958, 0.936, 1.021, 0.867, 1.071 (3G), 0.872, 0.911, 0.891, 0.852, 0.879, 1.019, 0.911, 0.933, 0.891, 0.933, 0.804, 0.911, 0.9, 0.891, 0.933, 0.911, 0.911, 0.918, 0.979, 1, 0.811, 0.852, 0.875, 0.911, 0.891, 0.827, 0.978, 0.915, 0.808, 0.863, 0.745, 0.902, 1.021, 0.825,  0.894, 0.891, 0.878, 0.902, 0.911, 0.741, 0.965, 0.86, 0.935, 0.84, 0.638, 0.872, 0.875, 0.911, 0.891, 0.791, 0.811, 0.872, 0.933, 0.721, 0.854, 0.891, 0.957, 0.9, 0.828 (2G), -0.891, -0.875, -0.911, -0.933, -0.788, -0.882, -0.911, -0.824, -0.906, -1.086, -0.915, -0.87, -0.894, -0.861, -0.957, -0.718, -0.75, -0.826, -0.911, -0.911, -0.911, -0.733, -0.851, -0.773, -0.757, -1.021, -0.965, -0.911, -1.043, -0.894, -0.766, -0.87, -0.891, -0.942, -0.945, -0.891, -0.916, -0.872, -0.891, -1, -0.911,  -0.719, -0.882, -0.891, -0.917, -0.911, -1.022, -0.911, -0.911, -0.894, -0.698, -0.894, -1, -0.935, -0.943, -0.857,  -0.707, -0.911, -0.942, -0.827, -0.981, -0.959, -0.911, -0.933, -0.943, -0.8, -0.911, -0.911, -0.872, -0.93, -0.978, -0.956, -0.896, -0.933, -0.843, -0.915, -0.891, -0.911, -0.855, -0.671, -0.891, -0.677, -0.911, -0.956, -0.944, -1, -0.911, -0.957, -0.86, -0.872, -0.872 (C-rich)]","PQS 22 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 57 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

PQS 72 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 81 (3G) of QGRS mapper and the PQS 24 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) from G4 hunter has a left frame-shift as compared to PQS 81 (3G) from QGRS mapper.

PQS 103 (3G) of QGRS mapper and the PQS 31 (3G) of G4 hunter have similar G tracts.

PQS 116 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

PQS 41 (3G) from G4 hunter has a left frame-shift as compared to PQS 116 (3G) from QGRS mapper.

PQS 132 (3G) of QGRS mapper and the PQS 46 (3G) of G4 hunter have similar G tracts.

PQS 143 (3G) of QGRS mapper and the PQS 48 (3G) of G4 hunter have similar G tracts.

PQS 48 (3G) from G4 hunter has a left frame-shift as compared to PQS 143 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 65 (3G) of G4 hunter have similar G tracts.

PQS 65 (3G) from G4 hunter has a left frame-shift as compared to PQS 187 (3G) from QGRS mapper.

PQS 215 (3G) of QGRS mapper and the PQS 69 (3G) of G4 hunter have similar G tracts.

PQS 219 (3G) of QGRS mapper and the PQS 70 (3G) of G4 hunter have similar G tracts.

PQS 262 (3G) of QGRS mapper and the PQS 89 (3G) of G4 hunter have similar G tracts.

PQS 297 (3G) of QGRS mapper and the PQS 105 (3G) of G4 hunter have similar G tracts.

PQS 299 (3G) of QGRS mapper and the PQS 108 (3G) of G4 hunter have similar G tracts.

PQS 310 (3G) of QGRS mapper and the PQS 115 (3G) of G4 hunter have similar G tracts.

PQS 317 (3G) of QGRS mapper and the PQS 117 (3G) of G4 hunter have similar G tracts.

PQS 345 (4G) of QGRS mapper and the PQS 128 (4G) of G4 hunter have similar G tracts.

PQS 351 (3G) of QGRS mapper and the PQS 133 (3G) of G4 hunter have similar G tracts.

PQS 362 (3G) of QGRS mapper and the PQS 135 (3G) of G4 hunter have similar G tracts.

PQS 381 (3G) of QGRS mapper and the PQS 139 (3G) of G4 hunter have similar G tracts.

PQS 397 (3G) of QGRS mapper and the PQS 147 (3G) of G4 hunter have similar G tracts.

PQS 398 (3G) of QGRS mapper and the PQS 148 (3G) of G4 hunter have similar G tracts.

PQS 148 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 150 (3G) of G4 hunter have similar G tracts.

PQS 150 (3G) from G4 hunter has a left frame-shift as compared to PQS 400 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 151 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 171 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 185 (3G) of G4 hunter have similar G tracts.

PQS 185 (3G) from G4 hunter has a left frame-shift as compared to PQS 577 (3G) from QGRS mapper.

By looking at PQS 69 and 70 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",24 (  12 - C-rich)  ,"[-1.333, -1.396,, -1.053, -1.195, -1.354, -1.511, -1.4, -1.422, -1.286, -1.293, -1.17, -1.4 (C-rich), 1.404, 1.178, 1.333, 1.381, 1.114, 1.37, 1.314, 1.396 (3G), 1.042, 1.372 (4G), 1.4, 1.4 (2G)]","PQS 128 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 128 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 194 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 345 (3G) of QGRS mapper and the PQS 14 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) from G4 hunter has a left frame-shift as compared to PQS 345 (3G) from QGRS mapper.

PQS 381 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) from G4 hunter has a left frame-shift as compared to PQS 381 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 19 and 20 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",,LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012
KCNQ1OT1,hypopharyngeal squamous cell carcinoma,"Microarray, qPCR, Western blot, Cell proliferation assay, Luciferase reporter assay, RIP, etc.",up-regulated,29970910.0,"Also Known As: LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012

Some (older-not checked for PQS) Long non-coding sense-intronic RNA Kcnq1ot1 (Kncq1 gene) ""lncRNA"" ncRNA (TPA: HG975405.1) was also there in result.",1,NR_002728.3,581,538,41,2,REVIEWED,"185 (59 - 2G, 32 - 3G, 3 - 4G, 91 - C-rich)","[0.914, 0.978, 1.23 (4G) 0.938, 0.942, 1.021, 0.911, 0.94, 1.008,  0.941, 0.627, 0.911, 0.765, 0.904, 0.691, 1.043, 0.886, 1.086, 0.911, 0.821, 0.957, 0.9, 0.852, 0.85, 0.73, 0.944, 0.754, 0.891, 0.857, 0.979, 0.958, 0.936, 1.021, 0.867, 1.071 (3G), 0.872, 0.911, 0.891, 0.852, 0.879, 1.019, 0.911, 0.933, 0.891, 0.933, 0.804, 0.911, 0.9, 0.891, 0.933, 0.911, 0.911, 0.918, 0.979, 1, 0.811, 0.852, 0.875, 0.911, 0.891, 0.827, 0.978, 0.915, 0.808, 0.863, 0.745, 0.902, 1.021, 0.825,  0.894, 0.891, 0.878, 0.902, 0.911, 0.741, 0.965, 0.86, 0.935, 0.84, 0.638, 0.872, 0.875, 0.911, 0.891, 0.791, 0.811, 0.872, 0.933, 0.721, 0.854, 0.891, 0.957, 0.9, 0.828 (2G), -0.891, -0.875, -0.911, -0.933, -0.788, -0.882, -0.911, -0.824, -0.906, -1.086, -0.915, -0.87, -0.894, -0.861, -0.957, -0.718, -0.75, -0.826, -0.911, -0.911, -0.911, -0.733, -0.851, -0.773, -0.757, -1.021, -0.965, -0.911, -1.043, -0.894, -0.766, -0.87, -0.891, -0.942, -0.945, -0.891, -0.916, -0.872, -0.891, -1, -0.911,  -0.719, -0.882, -0.891, -0.917, -0.911, -1.022, -0.911, -0.911, -0.894, -0.698, -0.894, -1, -0.935, -0.943, -0.857,  -0.707, -0.911, -0.942, -0.827, -0.981, -0.959, -0.911, -0.933, -0.943, -0.8, -0.911, -0.911, -0.872, -0.93, -0.978, -0.956, -0.896, -0.933, -0.843, -0.915, -0.891, -0.911, -0.855, -0.671, -0.891, -0.677, -0.911, -0.956, -0.944, -1, -0.911, -0.957, -0.86, -0.872, -0.872 (C-rich)]","PQS 22 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 57 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

PQS 72 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 81 (3G) of QGRS mapper and the PQS 24 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) from G4 hunter has a left frame-shift as compared to PQS 81 (3G) from QGRS mapper.

PQS 103 (3G) of QGRS mapper and the PQS 31 (3G) of G4 hunter have similar G tracts.

PQS 116 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

PQS 41 (3G) from G4 hunter has a left frame-shift as compared to PQS 116 (3G) from QGRS mapper.

PQS 132 (3G) of QGRS mapper and the PQS 46 (3G) of G4 hunter have similar G tracts.

PQS 143 (3G) of QGRS mapper and the PQS 48 (3G) of G4 hunter have similar G tracts.

PQS 48 (3G) from G4 hunter has a left frame-shift as compared to PQS 143 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 65 (3G) of G4 hunter have similar G tracts.

PQS 65 (3G) from G4 hunter has a left frame-shift as compared to PQS 187 (3G) from QGRS mapper.

PQS 215 (3G) of QGRS mapper and the PQS 69 (3G) of G4 hunter have similar G tracts.

PQS 219 (3G) of QGRS mapper and the PQS 70 (3G) of G4 hunter have similar G tracts.

PQS 262 (3G) of QGRS mapper and the PQS 89 (3G) of G4 hunter have similar G tracts.

PQS 297 (3G) of QGRS mapper and the PQS 105 (3G) of G4 hunter have similar G tracts.

PQS 299 (3G) of QGRS mapper and the PQS 108 (3G) of G4 hunter have similar G tracts.

PQS 310 (3G) of QGRS mapper and the PQS 115 (3G) of G4 hunter have similar G tracts.

PQS 317 (3G) of QGRS mapper and the PQS 117 (3G) of G4 hunter have similar G tracts.

PQS 345 (4G) of QGRS mapper and the PQS 128 (4G) of G4 hunter have similar G tracts.

PQS 351 (3G) of QGRS mapper and the PQS 133 (3G) of G4 hunter have similar G tracts.

PQS 362 (3G) of QGRS mapper and the PQS 135 (3G) of G4 hunter have similar G tracts.

PQS 381 (3G) of QGRS mapper and the PQS 139 (3G) of G4 hunter have similar G tracts.

PQS 397 (3G) of QGRS mapper and the PQS 147 (3G) of G4 hunter have similar G tracts.

PQS 398 (3G) of QGRS mapper and the PQS 148 (3G) of G4 hunter have similar G tracts.

PQS 148 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 150 (3G) of G4 hunter have similar G tracts.

PQS 150 (3G) from G4 hunter has a left frame-shift as compared to PQS 400 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 151 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 171 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 185 (3G) of G4 hunter have similar G tracts.

PQS 185 (3G) from G4 hunter has a left frame-shift as compared to PQS 577 (3G) from QGRS mapper.

By looking at PQS 69 and 70 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",24 (  12 - C-rich)  ,"[-1.333, -1.396,, -1.053, -1.195, -1.354, -1.511, -1.4, -1.422, -1.286, -1.293, -1.17, -1.4 (C-rich), 1.404, 1.178, 1.333, 1.381, 1.114, 1.37, 1.314, 1.396 (3G), 1.042, 1.372 (4G), 1.4, 1.4 (2G)]","PQS 128 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 128 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 194 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 345 (3G) of QGRS mapper and the PQS 14 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) from G4 hunter has a left frame-shift as compared to PQS 345 (3G) from QGRS mapper.

PQS 381 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) from G4 hunter has a left frame-shift as compared to PQS 381 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 19 and 20 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",,LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012
KTN1-AS1,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay,   etc",up-regulated,32267161.0,"Also known as: C14orf33, MYCLo-3",1,NR_027123.1,7,7,0,0,VALIDATED,3 (C-rich),"[-0.814, -0.914, -0.911 (C-rich)]","No similarity to PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,,MYCLo-3; C14orf33
LEF1-AS1,oral squamous cell carcinoma,"qRT-PCR , Western blot , in vitro knockdown etc.",up-regulated,30983488.0,Also Known As: LEF1NAT,2,"NR_029373.1, NR_029374.1","19, 9","17,9","2,0","0,0",VALIDATED,"8 (2 - 2G, 2 - 3G, 4 - C-rich);

0","[-1.026, -0.851, -0.781, -1.053, 0.917, 0.688 (2G), 0.887, 0.911 (3G)];

0","In variant 1, PQS 5 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) from G4 hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper.

In variant 1, PQS 9 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 8 (3G) from G4 hunter has a left frame-shift as compared to PQS 9 (3G) from QGRS mapper.","4 (C-rich);

0","[-1.28, -1.435, -1.4, -1.34 (C-rich)];

0","No similarity to PQS (2G) from QGRS mapper.
",,LEF1NAT
LINC-PINT,laryngeal cancer,"qRT-PCR, Western blot analysis etc.",down-regulated,31131448.0,"Also Known As: PINT; MKLN1-AS1; LincRNA-Pint

Some (older-not checked for PQS) Linc-pint lncRNA ""lncRNA"" ncRNA (partial sequence - MG322760.1) was also there in result.",13,"NR_015431.2, NR_024153.2, NR_109850.1, NR_109851.1, NR_109852.1, NR_109853.1, NR_109854.1, NR_109855.1, NR_034120.1, NR_110472.1, NR_110473.1, NR_170175.1, NR_170176.1","19, 8, 21, 19, 19, 15, 15, 15, 9, 8, 3, 23, 21","16,7,18,16,0,13,13,13,9,8,3,21,19","3,1,3,3,0,2,2,2,0,0,0,2,2","0,0,0,0,0,0,0,0,0,0,0,0,0",VALIDATED,"4 (2 - 2G, 2 - 3G);

1 (3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

0;

0;

0;

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G)","[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.885 {3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

0;

0;

0;

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)]","In variant 1, 3, 4, 5, 6, 7, 8, 12 and 13, PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

In variant 1, 3, 4, 5, 6, 7, 8, 12 and 13 PQS 10 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 10 (3G) from QGRS mapper.

In variant 2, PQS 3 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 3 (3G) from QGRS mapper.","0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0","0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0",No PQS found in G4 Hunter,,PINT; MKLN1-AS1; LincRNA-Pint
"LINC-POU3F3
PANTRI1",nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30602452.0,Also Known As: PANTRI1; LINC01158; linc-Brn1a; linc-POU3F3,4 (PANTRI1),"PANTRI1 (NR_037883.1, NR_131233.1, NR_131234.1, NR_131235.1)","13, 5, 5, 6 (PANTRI1)","12,5,6,6","1,0,0,0","0,0,0,0",VALIDATED (PANTRI1),"2 (1 - 3G, 1 - C-rich)

0;

1 (C-rich);

1 (C-rich)","[-0.616 (C-rich), 0.768 (3G)]; 

0;

[-0.616 (C-rich)];

[-0.616 (C-rich)]","In variant 1, PQS 13 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,LINC01158; linc-Brn1a; linc-POU3F3
LINC-ROR,oral cancer,qPCR,up-regulated,28443494.0,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3

Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.

Sequence not available for 1st variant (older).",2,"NR_048536.2, NR_152602.1","15, 13","15,13","0,0","0,0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,ROR; lincRNA-RoR; lincRNA-ST8SIA3
LINC-ROR,nasopharyngeal cancer,"qPCR, RNAi, Western blot, Flow cytometry assay etc.",up-regulated,27311700.0,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3

Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.

Sequence not available for 1st variant (older).",2,"NR_048536.2, NR_152602.1","15, 13","15,13","0,0","0,0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,ROR; lincRNA-RoR; lincRNA-ST8SIA3
LINC-ROR,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30601067.0,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3

Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.

Sequence not available for 1st variant (older).",2,"NR_048536.2, NR_152602.1","15, 13","15,13","0,0","0,0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,ROR; lincRNA-RoR; lincRNA-ST8SIA3
LINC00052,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,Also known as: TMEM83; NCRNA00052,1,NR_026869.1,5,5,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-0.841, -1.02 (C-rich), 0.707 (2G)]",No similarity to any PQS (2G) from QGRS mapper,1 (C-rich),[-1.472 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,,TMEM83; NCRNA00052
LINC00052,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31639333.0,Also known as: TMEM83; NCRNA00052,1,NR_026869.1,5,5,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-0.841, -1.02 (C-rich), 0.707 (2G)]",No similarity to any PQS (2G) from QGRS mapper,1 (C-rich),[-1.472 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,,TMEM83; NCRNA00052
LINC00114,nasopharyngeal cancer,"qPCR, Western blot, luciferase reporter assay etc",up-regulated,32196600.0,Also Known As: C21orf24; NCRNA00114,2,"NR_027065.2, NR_027066.2","4, 3","4,3","0,0","0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,C21orf24; NCRNA00114
LINC00114,nasopharyngeal cancer,"Microarray, qPCR etc.",up-regulated,27886062.0,Also Known As: C21orf24; NCRNA00114,2,"NR_027065.2, NR_027066.2","4, 3","4,3","0,0","0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,C21orf24; NCRNA00114
LINC00152,laryngeal squamous cell cancer,"qPCR, Luciferase reporter assay etc",up-regulated,32266320.0,Also Known As: C2orf59; LINC00152; NCRNA00152,5,"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1","4, 6, 4, 4, 3","4,6,4,4,3","0,0,0,0,0","0,0,0,0,0",REVIEWED,"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,C2orf59; LINC00152; NCRNA00152
LINC00152,tongue squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay etc",up-regulated,32194700.0,Also Known As: C2orf59; LINC00152; NCRNA00152,5,"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1","4, 6, 4, 4, 3","4,6,4,4,3","0,0,0,0,0","0,0,0,0,0",REVIEWED,"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,C2orf59; LINC00152; NCRNA00152
LINC00152,oral squamous cell carcinoma,"qPCR, Western blot, other",up-regulated,30310293.0,Also Known As: C2orf59; LINC00152; NCRNA00152,5,"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1","4, 6, 4, 4, 3","4,6,4,4,3","0,0,0,0,0","0,0,0,0,0",REVIEWED,"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,C2orf59; LINC00152; NCRNA00152
LINC00152,tongue squamous cell carcinoma,qPCR,up-regulated,28367232.0,Also Known As: C2orf59; LINC00152; NCRNA00152,5,"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1","4, 6, 4, 4, 3","4,6,4,4,3","0,0,0,0,0","0,0,0,0,0",REVIEWED,"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,C2orf59; LINC00152; NCRNA00152
LINC00210,nasopharyngeal cancer,"qPCR, RNAi, Luciferase reporter assay, RNAi, other",up-regulated,30341249.0,Also Known As: NCRNA00210,1,NR_048550.1,7,7,0,0,VALIDATED,2 (C-rich),"[-0.891, -0.693 (C-rich)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,NCRNA00210
LINC00210,nasopharyngeal cancer,"Microarray, qPCR etc.",up-regulated,27886062.0,Also Known As: NCRNA00210,1,NR_048550.1,7,7,0,0,VALIDATED,2 (C-rich),"[-0.891, -0.693 (C-rich)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,NCRNA00210
LINC00261,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,Also Known As: ALIEN; DEANR1; FALCOR; HCCDR1; C20orf56; NCRNA00261; TCONS_00027846; onco-lncRNA-17,1,NR_001558.3,31,31,0,0,REVIEWED,"6 (2 - 2G, 4 - C-rich)","[-0.935, -0.818, -0.865, -0.911 (C-rich), 0.787, 0.958 (3G)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,ALIEN; DEANR1; FALCOR; HCCDR1; C20orf56; NCRNA00261; TCONS_00027846; onco-lncRNA-17
LINC00261,laryngeal cancer,qPCR,down-regulated,29774690.0,Also Known As: ALIEN; DEANR1; FALCOR; HCCDR1; C20orf56; NCRNA00261; TCONS_00027846; onco-lncRNA-17,1,NR_001558.3,31,31,0,0,REVIEWED,"6 (2 - 2G, 4 - C-rich)","[-0.935, -0.818, -0.865, -0.911 (C-rich), 0.787, 0.958 (3G)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,ALIEN; DEANR1; FALCOR; HCCDR1; C20orf56; NCRNA00261; TCONS_00027846; onco-lncRNA-17
LINC00319,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, other",up-regulated,30243935.0,Also known as: PRED49; C21orf125; NCRNA00319,1,NR_152722.1,30,30,0,0,VALIDATED,"19 (1 - 2G, 18 - C-rich)
","[-0.891, -1.021, -0.911, -0.86, -0.894, -0.88, -0.86, -0.946, -0.922, -1.021, -0.825, -0.722, -1.043, -0.899, -0.888, -0.92, -1.043, -0.81 (C-rich), 0.83 (2G)] 
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,PRED49; C21orf125; NCRNA00319
LINC00355,head and neck squamous cell carcinoma,"Microarray, Dual Luciferase Reporter Gene Assay, qRT-PCR, Western blot analysis",up-regulated,31837606.0,,1,NR_145420.1,14,14,0,0,VALIDATED,1 (C-rich),[-0.933 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 355;HSALNG0097622;NONHSAG013685.2;HSALNG0097626;NONHSAG013688.2;LINC00355;HSALNG0097627;NONHSAG013687.2
LINC00460,head and neck squamous cell carcinoma,"qRT-PCR, Western blot, RIP",up-regulated,31737186.0,,2,"NR_034119.2, NR_163477.1","4, 4","4,4","0,0","0,0",VALIDATED,"2 (2G);

0","[0.911, 0.891 (2G)];

0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 460;HSALNG0099182;NONHSAG014130.2;LINC00460
LINC00460,head and neck squamous cell carcinoma,"qRT-PCR , Luciferase reporter assay etc.",up-regulated,31075234.0,,2,"NR_034119.2, NR_163477.1","4, 4","4,4","0,0","0,0",VALIDATED,"2 (2G);

0","[0.911, 0.891 (2G)];

0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 460;HSALNG0099182;NONHSAG014130.2;LINC00460
LINC00460,head and neck squamous cell carcinoma,"qPCR, Western blot, RNAi, RIP, other",up-regulated,31429766.0,,2,"NR_034119.2, NR_163477.1","4, 4","4,4","0,0","0,0",VALIDATED,"2 (2G);

0","[0.911, 0.891 (2G)];

0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 460;HSALNG0099182;NONHSAG014130.2;LINC00460
LINC00460,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, other",up-regulated,31414345.0,,2,"NR_034119.2, NR_163477.1","4, 4","4,4","0,0","0,0",VALIDATED,"2 (2G);

0","[0.911, 0.891 (2G)];

0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 460;HSALNG0099182;NONHSAG014130.2;LINC00460
LINC00460,nasopharyngeal cancer,"RNA-seq, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,28987345.0,,2,"NR_034119.2, NR_163477.1","4, 4","4,4","0,0","0,0",VALIDATED,"2 (2G);

0","[0.911, 0.891 (2G)];

0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 460;HSALNG0099182;NONHSAG014130.2;LINC00460
LINC00467,head and neck squamous cell carcinoma,"RT-qPCR, Western blot",up-regulated,32159247.0,Also Known As: C1orf97,1,NR_026761.2,5,5,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,C1orf97
LINC00472,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,"Also Known As: P53RRA; C6orf155

PQS 1 obtained in 4th variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 3 was taken.",4,"NR_121612.1, NR_026807.2, NR_121613.1, NR_121614.1","43, 43, 42, 43","41,41,40,41","2,2,2,2","0,0,0,0",VALIDATED,"8 (3 - 2G, 2 - 3G, 3 - C-rich);

8 (3 - 2G, 2 - 3G, 3 - C-rich);

8 (3 - 2G, 2 - 3G, 3 - C-rich);

8 (3 - 2G, 2 - 3G, 3 - C-rich)","[-0.911, -0.989, -0.694 (C-rich), 0.817, 0.86 (3G), 0.872, 0.895, 0.911 (2G)];

[-0.911, -0.989, -0.694 (C-rich), 0.817, 0.86 (3G), 0.872, 0.895, 0.911 (2G)];

[-0.911, -0.989, -0.694 (C-rich), 0.817, 0.86 (3G), 0.872, 0.895, 0.911 (2G)];

[-0.911, -0.989, -0.694 (C-rich), 0.817, 0.86 (3G), 0.872, 0.895, 0.911 (2G)]","In all the variants, PQS 11 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 11 (3G) from QGRS mapper.

PQS 12 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 12 (3G) from QGRS mapper.

By looking at PQS 3 and 4 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);","(-1.426, -1.4, -1.519)

(-1.426, -1.4, -1.519)

(-1.426, -1.4, -1.519)

(-1.426, -1.4, -1.519)",No similarity to any PQS (2G) from QGRS mapper,,P53RRA; C6orf155
LINC00473,head and neck squamous cell carcinoma,"qPCR, Western blot, Microarray, other",up-regulated,30468475.0,Also Known As: LNC473; C6orf176; bA142J11.1,2,"NR_026860.1, NR_026861.1","12, 5","12,5","0,0","0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,LNC473; C6orf176; bA142J11.1
LINC00511,tongue squamous cell carcinoma,"Microarray, qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,29315846.0,Also Known As: LCAL5; onco-lncRNA-12,1,NR_033876.1,18,16,2,0,VALIDATED,"7 (4 - 2G, 2 - 3G, 1 - C-rich)","[1, 0.855 (3G), 0.878, 0.891, 0.911, 0.531 (2G), -0.864 (C-rich)] 
","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,LCAL5; onco-lncRNA-12
LINC00520,nasopharyngeal cancer,qPCR,up-regulated,30898716.0,Also Known As: LASSIE; C14orf34,2,"NR_026796.1, NR_026797.1","13, 13","12,12","1,1","0,0",VALIDATED,"4 (1 - 3G, 3 - C-rich);

4 (1 - 3G, 3 - C-rich)","[-0.786, -0.911, -0.846 (C-rich), 0.808 (3G)];

[-0.786, -0.911, -0.846 (C-rich), 0.808 (3G)]","In both variants, PQS 11 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 11 (3G) from QGRS mapper.","1 (3G);

1 (3G)","[1.154 (3G)];

[1.154 (3G)]","In both variants, PQS 11 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",,LASSIE; C14orf34
LINC00657,laryngeal squamous cell cancer,"Microarray, qPCR",down-regulated,30128795.0,Also Known As: LINC00657 (NORAD),1 (NORAD),NR_027451.1 (NORAD),30 (NORAD),25,5,0,VALIDATED (NORAD),"12 (2 - 2G, 5 - 3G, 5 - C-rich)

","[-0.911, -0.882, -0.825, -1.118, -0.938 (C-rich), 0.894, 0.778, 0.75, 1.167, 0.824 (3G), 0.681, 0.911 (2G)]
","PQS 4 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 29 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

PQS 12 (3G) from G4 hunter has a left frame-shift as compared to PQS 29 (3G) from QGRS mapper.

By looking at PQS 6 and 7 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",2 (3G),"[1.337, 1.354 (3G)]","PQS 27 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 27 (3G) from QGRS mapper.

PQS 29 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.",,LINC00657
LINC00662,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30705593.0,,1,NR_027301.1,6,5,1,0,VALIDATED,1 (C-rich),[-1 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 662;CTC-459F4.2;LINC00662;HSALNG0125113;NONHSAG025376.2;NONHSAG025379.2
LINC00668,laryngeal squamous cell cancer,"qPCR, other",up-regulated,30415008.0,,1,NR_034100.1,15,13,2,0,VALIDATED,"3 (1 - 3G, 2 - C-rich)","[1.146 (3G), -0.906, -0.875 (C-rich)]","
PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 668;HSALNG0119819;NONHSAG023287.2;LINC00668
LINC00668,oral squamous cell carcinoma,"RNAi, Western blot, qPCR, Luciferase reporter assays, RNA pull-down assays",up-regulated,28564590.0,,1,NR_034100.1,15,13,2,0,VALIDATED,"3 (1 - 3G, 2 - C-rich)","[1.146 (3G), -0.906, -0.875 (C-rich)]","
PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 668;HSALNG0119819;NONHSAG023287.2;LINC00668
LINC00673,tongue squamous cell carcinoma,"qPCR, RNAi, Cell migration and invasion assay, ISH etc.",up-regulated,28039470.0,Also known asSLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75,5,"NR_137281.2, NR_137280.2, NR_036488.1, NR_152515.1, NR_152516.1","26, 25, 23, 23, 27","24,23,22,22,25","2,2,1,1,2","0,0,0,0,0",VALIDATED,"9 (2 - 2G, 2 - 3G, 5 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich)","[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];
 
(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)]","In variants 1, 2 and 5, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

In variants 3 and 4, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75
LINC00886,laryngeal cancer,qRT-PCR,down-regulated,32111441.0,,1,NR_038387.1,13,12,1,0,VALIDATED,"3 (1 - 3G, 2 - C-rich)","[-0.917, -0.896 (C-rich), 0.921 (3G)]","PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 4 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 886;LINC00886;HSALNG0030069;NONHSAG036477.2
LINC00958,nasopharyngeal cancer,"RT-qPCR, Luciferase Reporter Assay, RIP, Western blot analysis",up-regulated,31819474.0,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1,NR_038904.1,10,10,0,0,VALIDATED,1 (C-rich),[-0.86 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT2
LINC00958,oral squamous cell carcinoma,"qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31161900.0,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1,NR_038904.1,10,10,0,0,VALIDATED,1 (C-rich),[-0.86 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT2
LINC00958,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,31442551.0,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1,NR_038904.1,10,10,0,0,VALIDATED,1 (C-rich),[-0.86 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT2
LINC00958,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, other",up-regulated,31413594.0,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1,NR_038904.1,10,10,0,0,VALIDATED,1 (C-rich),[-0.86 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,BLACAT2
LINC00963,head and neck cancer,"qPCR, in vitro knockdown",up-regulated,32357409.0,Also Known As: MetaLnc9,1,NR_038955.1,21,20,1,0,VALIDATED,"3 (1 - 3G, 2 - C-rich)","[0.776 (3G), -0.891, -0.731 (C-rich)]","PQS 4 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",0,0,No PQS found in G4 Hunter,,MetaLnc9
LINC00974,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,31702382.0,,1,NR_038442.1,12,12,0,0,VALIDATED,"6 (1 - 2G, 5 - C-rich)","[-0.908, -0.888, -0.911, -0.911, -0.989 (C-rich),  0.935 (2G)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 974;NONHSAG021780.2;LINC00974;HSALNG0141637
LINC01116,nasopharyngeal cancer,"qRT-PCR, Western blot",up-regulated,31703161.0,Also Known As: TALNEC2,1,NR_040001.2,2,2,0,0,VALIDATED,1 (C-rich),[-0.741 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,TALNEC2
LINC01116,head and neck squamous cell carcinoma,"qPCR, Western blot, other",up-regulated,31452270.0,Also Known As: TALNEC2,1,NR_040001.2,2,2,0,0,VALIDATED,1 (C-rich),[-0.741 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,TALNEC2
LINC01116,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31308744.0,Also Known As: TALNEC2,1,NR_040001.2,2,2,0,0,VALIDATED,1 (C-rich),[-0.741 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,TALNEC2
LINC01133,nasopharyngeal cancer,"qRT-PCR , Western blot , RIP , RNAi , in vitro knockdown etc.",down-regulated,31106003.0,,1,NR_038849.1,7,7,0,0,VALIDATED,2 (C-rich),"[-0.803, -0.701 (C-rich)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 1133;lncRNA-PAGBC;prognosis-associated gallbladder cancer lncRNA;LINC01133;HSALNG0007801;NONHSAG003198.2
LINC01133,oral squamous cell carcinoma,"qPCR, Western blot, other",down-regulated,30332510.0,,1,NR_038849.1,7,7,0,0,VALIDATED,2 (C-rich),"[-0.803, -0.701 (C-rich)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,long intergenic non-protein coding RNA 1133;lncRNA-PAGBC;prognosis-associated gallbladder cancer lncRNA;LINC01133;HSALNG0007801;NONHSAG003198.2
LINC01234,oral squamous cell carcinoma,"RT-qPCR, Western blot",up-regulated,32041570.0,Also Known As: LCAL84; onco-lncRNA-32,2,"NR_110026.1, NR_110025.1","8, 9","7,8","1,1","0,0",VALIDATED,"8 (5 - 2G, 1 - 3G, 2 - C-rich);

8 (5 - 2G, 1 - 3G, 2 - C-rich)","[0.885 (3G), 0.857, 0.891, 0.915, 0.891, 0.911 (2G) -0.978, -0.857 (C-rich)]; 

[0.885 (3G), 0.857, 0.891, 0.915, 0.891, 0.911 (2G) -0.978, -0.857 (C-rich)];","In both variants, PQS 3 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,LCAL84; onco-lncRNA-32
LINCRNA-p21,head and neck cancer,qPCR etc.,down-regulated,26482616.0,"Also Known As: linc-p21; TRP53COR1; lincRNA-p21

Some (older) hLincRNA-p21_SIsoE1 lncRNA and LIsoE2 lncRNA (TP53COR1); ""lncRNA"" ncRNA (complete sequence-KU881769.1 and KU881768.1 respectively; note=""tumor protein p53 pathway corepressor 1 transcript variant SIsoE1 and LIsoE2"") were there in result.




Complement mentioned in gene, ncRNA, exon, repeat region feature details.

Annotation information: not in current annotation release.
",2 [TP53COR1 (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2)],"TP53COR1 (older) (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2) (KU881769.1, KU881768.1 respectively)","18, 19 [TP53COR1 (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2)]",,,,,,,,,,,,
LINCRNA-p21,head and neck squamous cell carcinoma,qPCR,down-regulated,30857539.0,"Also Known As: linc-p21; TRP53COR1; lincRNA-p21

Some (older) hLincRNA-p21_SIsoE1 lncRNA and LIsoE2 lncRNA (TP53COR1); ""lncRNA"" ncRNA (complete sequence-KU881769.1 and KU881768.1 respectively; note=""tumor protein p53 pathway corepressor 1 transcript variant SIsoE1 and LIsoE2"") were there in result.




Complement mentioned in gene, ncRNA, exon, repeat region feature details.

Annotation information: not in current annotation release.
",2 [TP53COR1 (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2)],"TP53COR1 (older) (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2) (KU881769.1, KU881768.1 respectively)","18, 19 [TP53COR1 (hLincRNA-p21_SIsoE1 and hLincRNA-p21_LIsoE2)]",,,,,,,,,,,,
lnc-C22orf32-1,nasopharyngeal cancer,qPCR,up-regulated,28588717.0,Also Known As: C22orf32-1; lnc-C22orf32-1,3,"NR_120595.1, NR_120596.1, 
NR_120597.1","13,9,3","12,8,2","1,1,1","0,0,0",VALIDATED,"1 (1 - 3G, 2 - C-rich);

1 (3G);

1 (3G)","[0.913 (3G), -0.847, -0.719 (C-rich);

[0.913 (3G)];

[0.913 (3G)]","In variant 1, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

In variants 2 and 3, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,C22orf32-1; lnc-C22orf32-1
lnc-C22orf32-1,nasopharyngeal cancer,"Microarray, qPCR etc.",up-regulated,24822202.0,Also Known As: C22orf32-1; lnc-C22orf32-1,3,"NR_120595.1, NR_120596.1, 
NR_120597.1","13,9,3","12,8,2","1,1,1","0,0,0",VALIDATED,"1 (1 - 3G, 2 - C-rich);

1 (3G);

1 (3G)","[0.913 (3G), -0.847, -0.719 (C-rich);

[0.913 (3G)];

[0.913 (3G)]","In variant 1, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

In variants 2 and 3, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,C22orf32-1; lnc-C22orf32-1
lnc-KCTD6-3,tongue cancer,"RNA-seq, qPCR etc.",down-regulated,25904139.0,Also Known As: lnc-KCTD6-3,1,NR_134853.1,7,7,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-0.938, -0.757 (C-rich), 0.956 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,lnc-KCTD6-3
lnc-KCTD6-3,laryngeal cancer,"RNA-seq, qPCR etc.",down-regulated,25904139.0,Also Known As: lnc-KCTD6-3,1,NR_134853.1,7,7,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-0.938, -0.757 (C-rich), 0.956 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,lnc-KCTD6-3
lncAROD,head and neck squamous cell carcinoma,"qPCR, Western blot, RIP etc",up-regulated,32216017.0,Also Known As: A-ROD; LINC01468; lnc-MBL2-4,2,"NR_120641.1, NR_120642.1","4,6","4,6","0,0","0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,A-ROD; LINC01468; lnc-MBL2-4
lncHIFCAR,oral cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc.",up-regulated,28639619.0,Also Known As: MIR31HG; hsa-lnc-31,4,"NR_027054.2, NR_152877.1,
NR_152878.1, NR_152879.1","20,13,12,19","19,13,12,18","1,0,0,1","0,0,0,0",REVIEWED,"7 (2 - 3G, 5 - C-rich);

5 (C-rich);

4 (C-rich);

6 (2 - 3G, 4 - C-rich)","[1.034, 0.94 (3G), -0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich);

[-0.9, -0.789, -0.911, -0.936 (C-rich)];

[1.034, 0.94 (3G), -0.9, -0.789, -0.911, -0.936 (C-rich)]","In  variant 1, PQS 5 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In variant 2 and 3, no similarity to any PQS from QGRS mapper is found.

In variant 4,  PQS 5 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,LncHIFCAR; hsa-lnc-31
lncRNA-LET,nasopharyngeal cancer,"qPCR, Western blot, RIP etc.",down-regulated,28615956.0,,1,NR_103844.1,13,13,0,0,VALIDATED,"11 (3 - 2G, 9 - C--rich)","[-0.647, -0.913, -0.911, -0.913, -0.933, -0.872, -0.783, -0.852 (C-rich), 0.935, 0.935, 0.911, 0.935 (2G)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,lncRNA-LET
lncRNA-LET,nasopharyngeal cancer,"qPCR, RNAi, Western blot etc.",down-regulated,26243049.0,,1,NR_103844.1,13,13,0,0,VALIDATED,"11 (3 - 2G, 9 - C--rich)","[-0.647, -0.913, -0.911, -0.913, -0.933, -0.872, -0.783, -0.852 (C-rich), 0.935, 0.935, 0.911, 0.935 (2G)]
","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,lncRNA-LET
lncRNA-NEF,laryngeal squamous cell cancer,"qRT-PCR , Western blot etc.",down-regulated,31186702.0,Also Known As: LINC01384; lncRNA-NEF,1,NR_109883.1,4,4,0,0,VALIDATED,1 (C-rich),[-0.913 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC01384; lncRNA-NEF
lncRNA-SRA1,laryngeal squamous cell cancer,qPCR etc.,down-regulated,25257554.0,Also Known As: lncRNA00673; LINC00673 [mentioned in qRT-PCR primers table in paper for lncRNA00673 (PubMed-29077173)]; SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75,5 (LINC00673),"LINC00673 (NR_137281.2, NR_137280.2, NR_036488.1, NR_152515.1, NR_152516.1)","26, 25, 23, 23, 27 (LINC00673)","24,23,22,22,25","2,2,1,1,2","0,0,0,0,0",REVIEWED (LINC00673),"9 (2 - 2G, 2 - 3G, 5 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich)","[1, 0.911 (2G), 0.766, 0.935 (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935 (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935 (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)]","In variants 1, 2 and 5, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

In variants 3 and 4, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75
LOC100129148,nasopharyngeal cancer,"qPCR, RNAi, Western blot, Luciferase reporter assay, CCK-8 assay etc.",up-regulated,28328537.0,,1,NR_033999.1,3,3,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,uncharacterized LOC100129148;HSALNG0061734;lnc-KLRG2-2;NONHSAG048937.2
LOC553103,nasopharyngeal cancer,"Microarray, qPCR, RNAi, Luciferase reporter assay etc.",up-regulated,27584792.0,Also Known As: SLC22A5-AS1,1,NR_110997.1,13,11,2,0,VALIDATED,"5 (2 - 3G, 3 - C-rich)","[0.936, 0.885 (3G), -0.914, -0.933, -0.981 (C-rich)]","PQS 9 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 12 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.",1 (C-rich),[-1.306 (C-rich)],"No similarity to any PQS (2G) from QGRS mapper
",,SLC22A5-AS1
LOC554202,laryngeal squamous cell cancer,"qPCR, Western blot, RNAi etc.",up-regulated,29737563.0,"Also Known As: LOC554202; MIR31HG; LncHIFCAR; hsa-lnc-31

LOC554202 mentioned in title of paper (PubMed-22289355 and others) referred in MIR31HG_variants (NR_027054.2, NR_152877.1, NR_152878.1, NR_152879.1).

Aliases for MIR31HG Gene (From GeneCards database - GCID: GC09M021439)
MIR31 Host Gene
MIR31HG
MIR31 Host Gene (Non-Protein Coding)
Hsa-Lnc-31
LncHIFCAR
Long Noncoding HIF-1alpha Co-Activating RNA
Long Noncoding HIF-1I+/- Co-Activating RNA
Long Noncoding HIF-1 Co-Activating RNA
NONHSAG051889.2
HSALNG0070363
LOC554202

Alias symbols for MIR31HG (From HGNC databse - HGNC ID - HGNC:37187)
LOC554202
hsa-lnc-31
LncHIFCAR
MIR31 host gene (non-protein coding)
long noncoding HIF-1 co-activating RNA

Gene Synonyms for MIR31HG (From Ensembl database - Ensembl version - ENSG00000171889.5)
LOC554202, LncHIFCAR, hsa-lnc-31

mRNA clones (cDNA) sequences (BC021861.1 and BC011715.2) available, not for lncRNA.",4 (MIR31HG),"MIR31HG (NR_027054.2, NR_152877.1, NR_152878.1, NR_152879.1)","20, 13, 12, 19 (MIR31HG)","19,13,12,18","1,0,0,1","0,0,0,0",REVIEWED (MIR31HG),"7 (2 - 3G, 5 - C-rich);

5 (C-rich);

4 (C-rich);

6 (2 - 3G, 4 - C-rich)","[1.034, 0.94 (3G), -0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich);

[-0.9, -0.789, -0.911, -0.936 (C-rich)];

[1.034, 0.94 (3G), -0.9, -0.789, -0.911, -0.936 (C-rich)]","In  variant 1, PQS 5 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In variant 2 and 3, no similarity to any PQS from QGRS mapper is found.

In variant 4,  PQS 5 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,LncHIFCAR; hsa-lnc-31
LUCAT1,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown",down-regulated,31210306.0,Also Known As: SCAL1; SCAT5,2,"NR_103548.1, NR_103549.1","3, 2","3,2","0,0","0,0",VALIDATED,"0;

3 (2G)","0;

[0.879, 0.911, 0.911 (2G)] ","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,SCAL1; SCAT5
MALAT1,head and neck squamous cell carcinoma,"qPCR, in vitro knockdown",up-regulated,32366409.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,laryngeal and hypopharyngeal Carcinoma,"qPCR, RNAi etc",up-regulated,31792655.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,tongue squamous cell carcinoma,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30863103.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,laryngeal squamous cell cancer,"RT-PCR, Western blotting",up-regulated,31837057.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, ChIP",up-regulated,30118844.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,tongue squamous cell carcinoma,"qPCR, Western blot, etc.",up-regulated,30657561.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,oral squamous cell carcinoma,qPCR,up-regulated,31360193.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,laryngeal squamous cell cancer,qPCR etc.,up-regulated,25257554.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,tongue cancer,"qPCR, RNAi, Western blot, Luciferase reporter assay, MTT assay etc.",up-regulated,28260102.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP etc.",up-regulated,28926115.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,tongue squamous cell carcinoma,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27586393.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,tongue squamous cell carcinoma,"qPCR, RNAi, Western blot etc.",up-regulated,27353727.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,oral squamous cell carcinoma,"qPCR, RNAi, Western blot etc.",up-regulated,26522444.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,28857668.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,nasopharyngeal cancer,"Microarray, qPCR, Luciferase reporter assay, Cell migration and invasion assay etc.",differential expression,27584791.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,nasopharyngeal cancer,"qPCR, Western blot, RIP, Luciferase reporter assay etc.",up-regulated,26482776.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,nasopharyngeal cancer,qPCR etc.,down-regulated,28467811.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,nasopharyngeal cancer,"qPCR, Western blot etc.",up-regulated,23688988.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46,47,47","7,7,6","0,0,0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);

30 (16 - 2G, 9 - 3G, 5 - C-rich);

31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];

[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]
",No similarity to PQS (2G) from QGRS mapper,"2 (3G);

2 (3G);

2 (3G)","[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)];

[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",,HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MEG3,head and neck squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay etc",down-regulated,32277605.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,laryngeal squamous cell cancer,"qPCR, Western blot",down-regulated,30915750.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,oral squamous cell carcinoma,qPCR,up-regulated,30809930.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay, etc.",down-regulated,30556872.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,nasopharyngeal cancer,"qPCR, MSP-PCR, Western blot, FISH etc.",down-regulated,27597634.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,tongue squamous cell carcinoma,"Microarray, MSP-PCR, RNAi, Western blot etc.",down-regulated,24343426.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,oral squamous cell carcinoma,qPCR etc.,down-regulated,23292713.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,oral squamous cell carcinoma,"qPCR, Western blot etc.",down-regulated,28953964.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14,17,16,15,15,15,15,15,15,16,15,17,15,16,81","2,2,2,2,2,2,2,2,2,2,2,2,2,2,12","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

9 (2 - 2G, 7 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);
____;

9 (2 - 2G, 7 - C-rich);

8 (2 - 2G, 6 - C-rich);

4 (2 - 2G, 2 - C-rich);

4 (2 - 2G, 2 - C-rich);

20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MIAT,tongue squamous cell carcinoma,"qRT-PCR , Western blot etc.",up-regulated,31166624.0,Also Known As: RNCR2; GOMAFU; C22orf35; LINC00066; NCRNA00066; lncRNA-MIAT,4,"NR_003491.3, NR_033319.2, NR_033320.2, NR_033321.2","122, 118, 118, 119","104,100,100,101","18,18,18,18","0,0,0,0",REVIEWED,"53 (27 - 2G, 19 - 3G, 7 - C-rich)","[0.917, 0.989, 0.766, 0.747, 0.797, 0.841, 0.841, 1.016, 0.667, 0.938, 0.78, 0.911, 0.872, 0.911, 1, 0.882, 0.671, 0.915, 0.896 (3G), 0.904, 0.989, 0.891, 0.894, 0.933, 0.891, 0.854, 0.926, 0.957, 0.911, 0.784, 0.882, 0.764, 0.894, 0.875, 0.92, 0.837, 0.911, 0.816, 0.933, 0.911, 0.911, 0.885, 0.956, 0.878,  0.911, 0.911, 0.902 (2G), -0.933, -0.889, -0.714, -1.05, -0.915, -0.806, -0.939 (C-rich)] ","In all the variants, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 12 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 12 (3G) from QGRS mapper.

In all the variants, PQS 16 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.

In all the variants, PQS 18 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts

PQS 5 (3G) from G4 hunter has a left frame-shift as compared to PQS 18 (3G) from QGRS mapper.

In all the variants, PQS 20 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 20 (3G) from QGRS mapper.

In all the variants, PQS 30 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 59 (3G) of QGRS mapper and the PQS 25 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 61 (3G) of QGRS mapper and the PQS 27 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 63 (3G) of QGRS mapper and the PQS 29 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 73 (3G) of QGRS mapper and the PQS 33 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 81 (3G) of QGRS mapper and the PQS 38 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 96 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 96 (3G) of QGRS mapper and the PQS 42 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 96 (3G) of QGRS mapper and the PQS 43 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 96 (3G) of QGRS mapper and the PQS 44 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 96 (3G) of QGRS mapper and the PQS 45 (3G) of G4 hunter have similar G tracts.

By looking at PQS 41, 42, 43, 44 and 45 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In all the variants, PQS 106 (3G) of QGRS mapper and the PQS 50 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 108 (3G) of QGRS mapper and the PQS 51 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 122 (3G) of QGRS mapper and the PQS 53 (3G) of G4 hunter have similar G tracts.

PQS 53 (3G) from G4 hunter has a left frame-shift as compared to PQS 122 (3G) from QGRS mapper.","6 (3G);

6 (3G);

6 (3G);

6 (3G)","[1.211, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)];

[1.211, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)];

[1.211, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)]; 

[1.211, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)]","In all the variants, PQS 12 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 12 (3G) from QGRS mapper.

In all the variants, PQS 30 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 59 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 61 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 81 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

In all the variants, PQS 122 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) from G4 hunter has a left frame-shift as compared to PQS 122 (3G) from QGRS mapper.",,RNCR2; GOMAFU; C22orf35; LINC00066; NCRNA00066; lncRNA-MIAT
MINCR,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc",up-regulated,31760895.0,Also Known As: LINC01604,2,"NR_120682.1 ,NR_120683.1","3,3","3,3","0,0","0,0",REVIEWED,"3 (C-rich);

1 (C-rich)","[-0.933, -0.94, -0.768 (C-rich)];
 
[-0.933 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,LINC01604
MINCR,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30777615.0,Also Known As: LINC01604,2,"NR_120682.1 ,NR_120683.1","3,3","3,3","0,0","0,0",REVIEWED,"3 (C-rich);

1 (C-rich)","[-0.933, -0.94, -0.768 (C-rich)];
 
[-0.933 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,LINC01604
MIR100HG,laryngeal squamous cell cancer,qRT-PCR etc.,up-regulated,31114240.0,Also Known As: AGD1; lncRNA-N2; linc-NeD125,23,"NR_024430.2, NR_137175.1, NR_137176.1, NR_137177.1, NR_137178.1, NR_137179.1, NR_137180.1, NR_137181.1, NR_137182.1, NR_137183.1, NR_137184.1, NR_137185.1, NR_137186.1, NR_137187.1, NR_137188.1, NR_137189.1, NR_137190.1, NR_137191.1, NR_137192.1, NR_137193.1, NR_137194.1, NR_137195.1, NR_137196.1","8, 10, 6, 6, 7, 6, 7, 8, 8, 4, 4, 4, 3, 3, 4, 7, 7, 7, 3, 5, 4, 8, 8","8,10,6,6,7,6,7,8,8,4,4,4,5,5,7,10,11,12,4,7,7,7,7","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1","0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0",REVIEWED,"1 (2G);

3 (2G);

4 (C-rich);

4 (C-rich);

6 (1 - 2G, 5- C-rich);

6 (1 - 2G, 5- C-rich);

0;

0;

1 (2G);

1 (2G);

0;

0;

0;

0;

0;

3 (2G);

3 (2G);

3 (2G);

0;

0;

0;

5 (3-  2G, 2- C-rich);

5 (3-  2G, 2- C-rich)","[0.978 (2G)];

[0.911, 1.189, 0.943 (2G)];

[-0.564, -0.813, -1.02, -0.894 (C-rich)];

[-0.564, -0.813, -1.02, -0.894 (C-rich)];

[0.911 (2G), -0.564, -0.813, -1.02, -0.894, -0.836 (C-rich)];

[0.911 (2G), -0.564, -0.813, -1.02, -0.894, -0.836 (C-rich)];

0;

0;

[0.978 (2G)];

[0.978 (2G)];

0;

0;

0;

0;

0;

[0.911, 1.189, 0.943 (2G)];

[0.911, 1.189, 0.943 (2G)];

[0.911, 1.189, 0.943 (2G)];

0;

0;

0;

[0.896, 0.933, 1 (2G). -0.896, -1 (C-rich)];

[0.896, 0.933, 1 (2G), -0.896, -1 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,AGD1; lncRNA-N2; linc-NeD125
miR143HG,laryngeal squamous cell cancer,RT-qPCR,down-regulated,31872875.0,"Also Known As: CARMEN, MIR143HG",2 (CARMN),"NR_105059.1, NR_105060.1 (CARMN)","13,11(CARMN)","12,10","1,1","0,0",VALIDATED (CARMN),"6 (2 - 2G, 1 - 3G, 3 - C-rich);

6 (2 - 2G, 1 - 3G, 3 - C-rich)","[0.676 (3G), -0.887, -0.872, -0.959 (C-rich), 0.765, 0.911 (2G)];

[0.676 (3G), -0.887, -0.872, -0.959 (C-rich), 0.765, 0.911 (2G)]","In both the variants, PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,CARMEN; MIR143HG
MIR155HG,laryngeal squamous cell cancer,"qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc.",up-regulated,31081043.0,Also Known As: BIC; MIRHG2; NCRNA00172,1,NR_001458.3,5,5,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,BIC; MIRHG2; miPEP155; NCRNA00172
MIR22HG,laryngocarcinoma,"RT-qPCR, Western blot",down-regulated,32094308.0,Also Known As: C17orf91,4,"NR_028502.1, NR_028503.1, NR_028504.1, NR_028505.1","22, 16, 10, 10","20,15,9,9","2,1,1,1","0,0,0,0",VALIDATED,"9 (2 - 2G, 7 - C-rich);

6 (1 - 2G, 5 - C-rich);

2 (C-rich);

3 (C-rich)","[0.726, 0.981 (2G), -0.765, -0.926, -1.122, -0.721,  -0.911, -0.891, -0.911 (C-rich)];

[0.981 (2G), -0.765, -0.926, -0.911, -0.891, -0.911 (C-rich)];

[-0.909, -0.911 (C-rich)];

[-0.765, -0.926, -0.911 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"1 (C-rich);

0;

0;

0","[-1.306 (C-rich)];

0;

0;

0",No similarity to PQS (2G) from QGRS mapper,,C17orf91
MIR31HG,head and neck cancer,"qPCR, Western blot, other",up-regulated,30458787.0,Also Known As: LncHIFCAR; hsa-lnc-31,4,"NR_027054.2, NR_152877.1,
NR_152878.1, NR_152879.1","20,13,12,19","19,13,12,18","1,0,0,1","0,0,0,0",REVIEWED,"7 (2 - 2G, 5 - C-rich);

5 ( C-rich);

4 (C-rich);

6 (1 - 2G, 5 - C-rich);","[1.034, 0.94 (2G), -0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.9, -0.789, -0.911, -0.936 (C-rich)];

[1.034, 0.94 (2G), -0.9, -0.789, -0.911, -0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LncHIFCAR; hsa-lnc-31
MIR31HG,laryngeal squamous cell cancer,"Microarray, qPCR etc.",up-regulated,28033431.0,Also Known As: LncHIFCAR; hsa-lnc-31,4,"NR_027054.2, NR_152877.1,
NR_152878.1, NR_152879.1","20,13,12,19","19,13,12,18","1,0,0,1","0,0,0,0",REVIEWED,"7 (2 - 2G, 5 - C-rich);

5 ( C-rich);

4 (C-rich);

6 (1 - 2G, 5 - C-rich);","[1.034, 0.94 (2G), -0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];

[-0.9, -0.789, -0.911, -0.936 (C-rich)];

[1.034, 0.94 (2G), -0.9, -0.789, -0.911, -0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LncHIFCAR; hsa-lnc-31
MIR4435-2HG,oral squamous cell carcinoma,"RT-qPCR, Western blot",up-regulated,32016787.0,Also Known As: MIR4435-2HG; AGD2; MORRBID; LINC00978; MIR4435-1HG; lncRNA-AWPPH,8 (MIR4435-2HG),"MIR4435-2HG (NR_015395.2, NR_024373.2, NR_136161.1, NR_136162.1, NR_136163.1, NR_136164.1, NR_136165.1, NR_136166.1) ","23, 5, 10, 24, 15, 10, 8, 21 (MIR4435-2HG)","23,5,10,24,15,10,8,21","0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0",VALIDATED (MIR4435-2HG),"3 (C-rich);

1 (C-rich);

0;

5 (C-rich);

2 (C-rich);

2 (C-rich);

0;

3 (C-rich)","[-0.957, -0.922, -0.774 (C-rich)];

[-0.726 (C-rich)];

0;

[-0.957, -0.922, -0.774, -0.759, -0.872 (C-rich)];

[-0.859, -0.872 (C-rich)];

[-0.859, -0.872 (C-rich)];

0;

[-0.957, -0.922, -0.774 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,AGD2; MORRBID; LINC00978; MIR4435-1HG; lncRNA-AWPPH
MORT,oral squamous cell carcinoma,qPCR,down-regulated,30805944.0,Also Known As: ZNF667-AS1; MORT,2 (ZNF667-AS1),ZNF667-AS1 (NR_036521.1; NR_036522.1),"10, 5 (ZNF667-AS1)","9,4","1,1","0,0",VALIDATED (ZNF667-AS1),"7 (2 - 2G, 3 - 3G, 2 - C-rich);

7 (2 - 2G, 3 - 3G, 2 - C-rich)","[0.958, 0.911 (2G), 1, 1.04, 0.733 (3G), -0.933, -0.776 (C-rich)];

[0.958, 0.911 (2G), 1, 1.04, 0.733 (3G), -0.933, -0.776 (C-rich)]","In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a right frame-shift as compared to PQS 7 (3G) from QGRS mapper.

In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.","1 (3G);

1 (3G)","[1.422 (3G)];

[1.422 (3G)]","In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",,MORT
MRVI1-AS1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay",differential expression,31273338.0,Also Known As: IRAG1-AS1,4,"NR_046374.1, NR_046375.1,
NR_034093.2, NR_034094.2","7,6,6,6","7,6,6,6","0,0,0,0","0,0,0,0",VALIDATED,"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich)","[-0.918, -0.814 (C-rich)];

[-0.918, -0.814 (C-rich)];

[-0.918, -0.814 (C-rich)];

[-0.918, -0.814 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,MRVI1-AS1
MYOSLID,head and neck squamous cell carcinoma,"qPCR, Western blot",up-regulated,31238980.0,,1,NR_146555.1,7,7,0,0,VALIDATED,4 (C-rich),"[-0.857, -0.75, -0.984, -0.839 (C-rich)]
",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,"myocardin-induced smooth muscle lncRNA, inducer of differentiation;MYOSLID;HSALNG0021858;NONHSAG030360.2;HSALNG0021850"
NAG7,nasopharyngeal cancer,"Microarray, ISH etc.",down-regulated,23529758.0,Also known as: NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312,1,NR_024065.3,10,9,1,0,REVIEWED,2 (3G),"[0.957, 0.65 (3G)] ","In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.",0,0,No PQS found in G4 Hunter,,NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312
NAG7,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, ISH etc.",up-regulated,19591174.0,Also known as: NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312,1,NR_024065.3,10,9,1,0,REVIEWED,2 (3G),"[0.957, 0.65 (3G)] ","In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.",0,0,No PQS found in G4 Hunter,,NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312
NAG7,nasopharyngeal cancer,"Western blot, Northern blot etc.",down-regulated,12452030.0,Also known as: NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312,1,NR_024065.3,10,9,1,0,REVIEWED,2 (3G),"[0.957, 0.65 (3G)] ","In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

In both the variants, PQS 7 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.",0,0,No PQS found in G4 Hunter,,NAG7; ERR10; NAG-7; ERR-10; LMCD1DN; LOH3CR2A; NCRNA00312
NCK1-AS1,nasopharyngeal cancer,qRT-PCR,up-regulated,31908525.0,Also Known As: NCK1-DT; NCK1-AS1; SLC35G2-AS1,3 (NCK1-DT),"NCK1-DT (NR_110175.1, NR_110176.1, NR_110177.1)","9, 8, 7 (NCK1-DT)","9,8,7","0,0,0","0,0,0",VALIDATED (NCK1-DT),"3 (1 - 2G, 2 - C-rich);

3 (1 - 2G, 2 - C-rich);

3 (1 - 2G, 2 - C-rich)","[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)]","No similarity to any PQS (2G) from QGRS mapper
",0,0,No PQS found on G4 Hunter,,NCK1-AS1; SLC35G2-AS1
NEAT1,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30900419.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter gene assay.",up-regulated,30186464.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,laryngeal squamous cell cancer,"qPCR, Western blot, Luciferase reporter assay etc.",down-regulated,26822763.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,oral squamous cell carcinoma,qPCR etc.,up-regulated,23292713.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29484420.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,27020592.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,nasopharyngeal cancer,"qPCR, Western blot etc.",down-regulated,29565706.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,nasopharyngeal cancer,"qPCR, Western blot etc.",down-regulated,29050268.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, Western blot, RIP",up-regulated,29270022.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134,33","16,8","0,0",REVIEWED,"64 (39 - 2G, 25 - C-rich);

25 (23 - 2G, 2 - C-rich)","[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917,  0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816, 0.768, 0.891, 0.818, 0.896, 0.909, 0.929, 0.911, 0.875, 0.979, 0.857, 0.804, 1, 0.911, 0.857, 0.89, 0.891 (2G), -0.782, -0.851, -0.84, -0.957, -0.889, -0.885, -0.889, -0.74, -0.935, -0.935, -0.891, -0.891, -0.766, -0.921, -0.911, -0.911, -0.721, -0.896, -0.898, -0.857, -0.791, -0.891, -0.521, -0.784, -0.882 (C-rich)];

[0.937, 0.986, 0.911, 1.11, 0.825, 0.935, 0.901, 0.978, 0.81, 0.911, 0.86, 0.911, 0.821, 0.911, 0.917, 0.935, 1.148, 0.845, 0.891, 1.045, 0.854, 0.891, 0.816 (2G), -0.782, -0.851 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);

8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];

[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",,VINC; TncRNA; LINC00084; NCRNA00084
NKILA,nasopharyngeal cancer,"qPCR, other",down-regulated,31430288.0,,1,NR_131157.1,28,26,2,0,VALIDATED,"8 (2 - 2G, 1 - 4G, 5 - C-rich)
","[-0.911, -0.875, -0.8, -0.891, -0.646 (C-rich), 0.643, 0.911 (2G), 0.973 (4G)]
","No similarity to PQS (3G) from QGRS mapper

",1 (3G),[1.426 (3G)],"PQS 11 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",,NF-kappaB interacting lncRNA;NF-kappaB interacting long non-coding RNA;HSALNG0131196;lnc-PCK1-5;NONHSAG032126.2
NKILA,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc.",down-regulated,29573243.0,,1,NR_131157.1,28,26,2,0,VALIDATED,"8 (2 - 2G, 1 - 4G, 5 - C-rich)
","[-0.911, -0.875, -0.8, -0.891, -0.646 (C-rich), 0.643, 0.911 (2G), 0.973 (4G)]
","No similarity to PQS (3G) from QGRS mapper

",1 (3G),[1.426 (3G)],"PQS 11 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",,NF-kappaB interacting lncRNA;NF-kappaB interacting long non-coding RNA;HSALNG0131196;lnc-PCK1-5;NONHSAG032126.2
NKILA,tongue squamous cell carcinoma,"qPCR, Western blot, ISH etc.",down-regulated,27613832.0,,1,NR_131157.1,28,26,2,0,VALIDATED,"8 (2 - 2G, 1 - 4G, 5 - C-rich)
","[-0.911, -0.875, -0.8, -0.891, -0.646 (C-rich), 0.643, 0.911 (2G), 0.973 (4G)]
","No similarity to PQS (3G) from QGRS mapper

",1 (3G),[1.426 (3G)],"PQS 11 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",,NF-kappaB interacting lncRNA;NF-kappaB interacting long non-coding RNA;HSALNG0131196;lnc-PCK1-5;NONHSAG032126.2
NR2F2-AS1,nasopharyngeal cancer,"RT-qPCR, Western blotting",up-regulated,31966043.0,,3,"NR_102743.1, NR_102744.1, NR_125738.1","9,4,3","9,4,3","0,0,0","0,0,0",VALIDATED,"2 (2G);

0;

2 (C-rich)","[1, 0.891 (2G)];

0;

[-0.911, -0.821 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,NR2F2 antisense RNA 1;NR2F2 antisense RNA 1 (non-protein coding);HSALNG0108391;NR2F2-AS1;NONHSAG017999.2;HSALNG0108393;NONHSAG018003.2;HSALNG0108400;HSALNG0108394;HSALNG0108392;HSALNG0108404;HSALNG0108399
NR_003949 FKBP9P1_Variant 4,laryngeal squamous cell cancer,"Microarray, qPCR etc.",up-regulated,28033431.0,also known as: FKBP9L; FKBP9P1,"1
(Variants 1st, 2nd and 3rd are also lncRNAs)
(Total = 4) (FKBP9P1)","FKBP9P1 (_____, _____, _____, NR_003949.1)",,17,1,0,VALIDATED (FKBP9P1),,,,,,,,FKBP9L
NR_027358 LINC00592,nasopharyngeal cancer,"Microarray, qPCR etc.",down-regulated,25406670.0,,1 (LINC00592),LINC00592 (NR_027358.2),,8,0,0,VALIDATED (LINC00592),,,,,,,,long intergenic non-protein coding RNA 592;LINC00592;HSALNG0091158;NONHSAG011187.2
OIP5-AS1,laryngeal squamous cell cancer,"RT-qPCR, Western blot",up-regulated,32009213.0,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30,26,6,31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);

8 (3 - 2G, 5 - C-rich);

1 (C-rich);

8 (3 - 2G, 5 - C-rich)","[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[-0.872 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,cyrano; linc-OIP5
OIP5-AS1,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,31369989.0,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30,26,6,31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);

8 (3 - 2G, 5 - C-rich);

1 (C-rich);

8 (3 - 2G, 5 - C-rich)","[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[-0.872 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,cyrano; linc-OIP5
OIP5-AS1,oral cancer,"RNA-seq, Microarray, qPCR, Luciferase reporter assay, RIP etc.",up-regulated,29728583.0,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30,26,6,31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);

8 (3 - 2G, 5 - C-rich);

1 (C-rich);

8 (3 - 2G, 5 - C-rich)","[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];

[-0.872 (C-rich)];

[0.649, 0.656, 0.915 (2G), -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,cyrano; linc-OIP5
PANDAR,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown",up-regulated,31938389.0,Also Known As: PANDA,1,NR_109836.1,6,6,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,PANDA
PAPAS,oral squamous cell carcinoma,"RT-qPCR, Western blot analysis etc.",up-regulated,31099126.0,Also known as: H-PIP; PAPAS; CD2BP1; PSTPIP; CD2BP1L; CD2BP1S,"1
(Variants 1st, 2nd 3rd and 4th are mRNA)
(Total = 5)","____,____,____,____,NR_029708.1",,1,0,0,REVIEWED,,,,,,,,MIRN188; miR-188
PART1,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,Also Known As: NCRNA00206,3,"NR_024617.1, NR_028508.1, NR_028509.1","18, 11, 21","18,11,20","0,0,1","0,0,0",VALIDATED,"8 (6 - 2G, 2 - C-rich);
1  (2G);

14 (4 - 2G, 10 - C-rich)","[0.872, -0.86, -0.875, 0.872, 0.913, 0.913, 0.911, 0.911];
[0.872];

[0.872, -0.865, -0.804, 0.72, 0.788, 0.911, -0.843, -0.767, -0.83, -0.96, -0.837, -0.911, -0.911, -0.797]",No similarity to PQS (2G) from QGRS mapper,"0;

0;

1 (3G)","0; 

0; 

[1.014 (3G)]",PQS (3G) from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter for Variant 3,,NCRNA00206
PCAT1,laryngeal cancer,"RT-qPCR, RIP",up-regulated,31983116.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,PCA1; PiHL; PCAT-1
PCAT1,tongue squamous cell carcinoma,"qPCR, Western blot etc",up-regulated,32218838.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,PCA1; PiHL; PCAT-1
PCAT1,head and neck squamous cell carcinoma,"qRT-PCR , Western blot , in vitro knockdown etc.",up-regulated,30987615.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,PCA1; PiHL; PCAT-1
PCAT7,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,28728844.0,,4,"NR_121566.2, NR_121567.2 , NR_121568.2, NR_121569.2 ","16, 15, 11, 15","15,14,10,14","1,1,1,1","0,0,0,0",VALIDATED,"5 (2G);

5 (2G);

2 (2G);

5 (2G)","[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];

[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];

[0.746, 0.872 (2G)];

[0.879, 0.891, 0.904, 0.746, 0.872 (2G)]",No similarity to PQS (2G) from QGRS mapper,"0;

0;

0;

0","0;

0;

0;

0",No PQS found in G4 Hunter,,PCAN-R2
PCAT7,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi etc.",up-regulated,28728844.0,,4,"NR_121566.2, NR_121567.2 , NR_121568.2, NR_121569.2 ","16, 15, 11, 15","15,14,10,14","1,1,1,1","0,0,0,0",VALIDATED,"5 (2G);

5 (2G);

2 (2G);

5 (2G)","[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];

[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];

[0.746, 0.872 (2G)];

[0.879, 0.891, 0.904, 0.746, 0.872 (2G)]",No similarity to PQS (2G) from QGRS mapper,"0;

0;

0;

0","0;

0;

0;

0",No PQS found in G4 Hunter,,PCAN-R2
PDIA3P,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay, RNAi",up-regulated,29246288.0,Also known as: ERp60; GRP58P; PDIA3P,1,NR_002305.1,,10,1,0,VALIDATED,,,,,,,,ERp60; GRP58P; PDIA3P
PEG10,hypopharyngeal squamous cell carcinoma,qPCR,up-regulated,28928830.0,"Also Known As: Huh7; PGSF1; C19orf30; 
LINC00306; NCRNA00306; uc002mbe.2",1,NR_027148.1,7,6,1,0,VALIDATED,"4 (1 - 2G, 1 - 3G, 2 - C-rich)
","[0.989 (3G), 0.911 (2G), -0.958, -0.839 (C-rich)]
","PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.",0,0,No PQS found in G4 Hunter,,Huh7; PGSF1; C19orf30; LINC00306; NCRNA00306; uc002mbe.2
PLAC2,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,30720068.0,Also Known As: PLAC2; LINC00036; NCRNA00036; onco-lncRNA-16,1,NR_027064.3,40,30,10,0,REVIEWED,"24 (15- 2G, 9 - C-rich)","[1.184, 1.04, 0.936, 0.884, 0.877, 0.87, 0.766, 1.136, 0.885, 0.865, 0.655, 0.542, 1, 0.911, 0.745 (2G) -0.836, -0.978, -1, -0.847, -0.833, -0.774, -0.956, -1.075, -0.891]",No similarity to PQS (2G) from QGRS mapper,"10 (2 - 3G, 8 - C-rich)","[1.373, 1.604 (3G); -1.391, -1.422, -1.354, 1.347, -1.4, -1.5, -1.489, -1.375 (C-rich)]",No similarity to PQS (3G) from QGRS Mapper,,TINCR ubiquitin domain containing;FLJ90734;NCRNA00036;LINC00036;onco-lncRNA-16;non-protein coding RNA 36;long intergenic non-protein coding RNA 36;terminal differentiation-induced ncRNA;placenta-specific 2;placenta-specific 2 (non-protein coding);tissue differentiation-inducing non-protein coding RNA;PLAC2;NONHSAG024566.2;lnc-TINCR-1;HSALNG0123467;HSALNG0123468;Ubiquitin domain-containing protein TINCR;Placenta-specific protein 2;Terminal differentiation-induced cornification regulator
PTCSC3,laryngeal squamous cell cancer,"qRT-PCR , Western blot etc.",down-regulated,31171714.0,,1,NR_049735.2,8,8,0,0,VALIDATED,1 (2G),[0.709 (2G)],"No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,papillary thyroid carcinoma susceptibility candidate 3;papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding);HSALNG0100636;PTCSC3;NONHSAG014723.2
PTENP1,oral squamous cell carcinoma,"qPCR, other",,30229832.0,"Processed pseudogene;
Also known as
PTH2; PTEN2; PTEN-rs; PTENpg1; psiPTEN;
Search Results for PTENP1-AS also displayed",1,HG975434.1,20,,,,REVIEWED,,,,,,,,"phosphatase and tensin homolog pseudogene 1;PTEN2;psiPTEN;PTH2;PTEN-rs;PTENpg1;phosphatase and tensin homolog pseudogene 1 (functional);PTEN/MMAC1 pseudogene;phosphatase and tensin homolog (mutated in multiple advanced cancers 1), pseudogene 1"
PTPRG-AS1,nasopharyngeal cancer,"qRT-PCR, Western blotting, Microarray data analysis etc.",up-regulated,30993702.0,,3,"NR_038281.1, NR_038282.1,
NR_038283.1","6,7,6","6,7,6","0,0,0","0,0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,PTPRG antisense RNA 1;PTPRG-AS1;HSALNG0026508;NONHSAG035305.2;HSALNG0026507
PVT1,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,32021271.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PVT1,nasopharyngeal cancer,"qPCR, Western blot",up-regulated,30141114.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PVT1,head and neck squamous cell carcinoma,"qPCR, Western blot, other",up-regulated,30310517.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PVT1,laryngeal squamous cell cancer,"qPCR, Western blot, Luciferase reporter assay, Microarray, other",up-regulated,30304557.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PVT1,nasopharyngeal cancer,"qPCR, Western blot, RIP",up-regulated,31320749.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PVT1,nasopharyngeal cancer,"Microarray, qPCR, Western blot, in vitro knockdown",up-regulated,29445147.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G) -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100
PXN-AS1-L,nasopharyngeal cancer,"qPCR , Luciferase reporter assay , Western blot etc.",up-regulated,31173488.0,,1,NR_038924.1,8,8,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,EyeLinc4
RBM5-AS1,oral squamous cell carcinoma,"RT-qPCR, Luciferase activity assays, Western blot assay",up-regulated,31869662.0,"Also Known As: LUST

Some SEMA3F antisense RNA 1 (SEMA3F-AS1), long non-coding RNA ""lncRNA"" ncRNA (NR_135301.1) with PQS-22 (2G), 2 (3G) was also there in result.",1,NR_045388.1,2,1,1,0,REVIEWED,"2 (1 - 2G, 1 - 3G)","[0.939 (3G), 0.837 (2G)] ","PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
",0,0,No PQS found in G4 Hunter,,LUST
RGMB-AS1,laryngeal squamous cell cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,31351424.0,,1,NR_033932.1,17,14,3,0,VALIDATED,"6 (4 - 3G, 2 - C-rich)","[0.792, 0.661, 1, 0.84 (3G), -0.896, -0.841 (3G)]
","PQS 10 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 13 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 13 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.

PQS 15 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 Hunter,,RGMB antisense RNA 1;CTC-463N11.3;HSALNG0043698;RGMB-AS1;NONHSAG041111.2
RHPN1-AS1,head and neck squamous cell carcinoma,"qPCR, Western blot, RNAi, other",up-regulated,31417644.0,"Homo sapiens RHPN1 antisense RNA 1 (head to head) (RHPN1-AS1), long non-coding RNA

Also Known As: C8orf51",1,NR_026785.1,16,16,0,0,VALIDATED,6 (C-rich),"[-0.911, -0.978, -0.985, -0.918, -0.933, -0.818 (C-rich)
 
",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,C8orf51
ROR1-AS1,nasopharyngeal cancer,"RT-qPCR, Western blot analysis, Luciferase Assays, RIP",up-regulated,31957830.0,,2,"NR_110665.1, NR_110666.1","7,11","7,11","0,0","0,0",VALIDATED,"0;

1 (C-rich)","0;

[-0.917 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,ROR1 antisense RNA 1;HSALNG0004143;NONHSAG001712.2;ROR1-AS1
SATB1-AS1,laryngeal squamous cell cancer,qRT-PCR,down-regulated,32174248.0,,1,NR_125803.1,7,5,2,0,VALIDATED,1 (4G),[1.03 (4G)],No similarity to PQS (2G) from QGRS mapper,1 (4G),[1.464 (4G)],No similarity to PQS (4G) from QGRS mapper,,SATB1 antisense RNA 1;HSALNG0024541;SATB1-AS1;NONHSAG034569.2
SMAD5-AS1,nasopharyngeal cancer,Microarray,up-regulated,31557058.0,Also Known As: DAMS; SMAD5AS; SMAD5OS,1,NR_026763.1,7,7,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-1.019, -1.085 (C-rich), 0.688 (2G)] ","No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,DAMS; SMAD5AS; SMAD5OS
SMAD5-AS1,nasopharyngeal cancer,"RT-qPCR, Dual Luciferase Reporter Gene Assay, RIP, Western blot analysis",up-regulated,31921616.0,Also Known As: DAMS; SMAD5AS; SMAD5OS,1,NR_026763.1,7,7,0,0,VALIDATED,"3 (1 - 2G, 2 - C-rich)","[-1.019, -1.085 (C-rich), 0.688 (2G)] ","No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,DAMS; SMAD5AS; SMAD5OS
SNHG1,laryngeal squamous cell cancer,"qPCR, Western blot, RNAi, RIP, Microarray, other",up-regulated,30323965.0,Also Known As: C20orf198; LINC00101; NCRNA00101,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1,
NR_152582.1, NR_152583.1,
NR_152584.1, NR_152585.1



","5,9,9,4,4,4,4,4,5,
3,7,7","5,9,9,4,4,4,4,4,5,3,7,7","0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0",VALIDATED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG1,laryngeal cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,31378897.0,Also Known As: C20orf198; LINC00101; NCRNA00101,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1,
NR_152582.1, NR_152583.1,
NR_152584.1, NR_152585.1



","5,9,9,4,4,4,4,4,5,
3,7,7","5,9,9,4,4,4,4,4,5,3,7,7","0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0",VALIDATED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG1,laryngeal squamous cell cancer,"qPCR, Western blot, RNAi etc.",up-regulated,29565491.0,Also Known As: C20orf198; LINC00101; NCRNA00101,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1,
NR_152582.1, NR_152583.1,
NR_152584.1, NR_152585.1



","5,9,9,4,4,4,4,4,5,
3,7,7","5,9,9,4,4,4,4,4,5,3,7,7","0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0",VALIDATED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29575772.0,Also Known As: C20orf198; LINC00101; NCRNA00101,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1,
NR_152582.1, NR_152583.1,
NR_152584.1, NR_152585.1



","5,9,9,4,4,4,4,4,5,
3,7,7","5,9,9,4,4,4,4,4,5,3,7,7","0,0,0,0,0,0,0,0,0,0,0,0","0,0,0,0,0,0,0,0,0,0,0,0",VALIDATED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG16,oral squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30607006.0,Also Known As: SNHG16; ncRAN; Nbla10727; Nbla12061,4 (SNHG16),"SNHG16 (NR_038108.1, NR_038109.1, NR_038110.1, NR_038111.1)","9, 9, 8, 8 (SNHG16)","9,9,8,8","0,0,0,0","0,0,0,0",VALIDATED (SNHG16),"1  (C-rich);

1  (C-rich);

1  (C-rich);

1  (C-rich)","[-0.819 (C-rich)];

[-0.819 (C-rich)];

[-0.819 (C-rich)];

[-0.819 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,ncRAN; Nbla10727; Nbla12061
SNHG20,laryngeal squamous cell cancer,"qPCR , Luciferase reporter assay , in vitro knockdown etc.",up-regulated,31081112.0,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,C17orf86; LINC00338; NCRNA00338; SCARNA16HG
SNHG20,oral squamous cell carcinoma,"qPCR, Western blot, RNAi, Luciferase reporter assay, other",up-regulated,30394668.0,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,C17orf86; LINC00338; NCRNA00338; SCARNA16HG
SNHG20,oral squamous cell carcinoma,"qPCR, Western blot, etc.",up-regulated,30655853.0,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,C17orf86; LINC00338; NCRNA00338; SCARNA16HG
SNHG20,nasopharyngeal cancer,"qPCR, Western blot, etc.",up-regulated,30546404.0,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,C17orf86; LINC00338; NCRNA00338; SCARNA16HG
SNHG3,oral squamous cell carcinoma,"qPCR, Western blot, RIP etc",up-regulated,31762107.0,Also Known As: U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014,2,"NR_036473.1, NR_002909.2","18, 16","18,16","0,0","0,0",VALIDATED,"3 (2G);

3 (2G)","[0.933, 0.894, 0.828 (2G)];

[0.933, 0.894, 0.828 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014
SNHG3,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31238052.0,Also Known As: U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014,2,"NR_036473.1, NR_002909.2","18, 16","18,16","0,0","0,0",VALIDATED,"3 (2G);

3 (2G)","[0.933, 0.894, 0.828 (2G)];

[0.933, 0.894, 0.828 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014
SNHG5,nasopharyngeal cancer,"RT-qPCR, Western blot",up-regulated,32131767.0,Also Known As: U50HG; C6orf160; LINC00044; NCRNA00044,1,NR_003038.2,2,2,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,U50HG; C6orf160; LINC00044; NCRNA00044
SNHG6,tongue cancer,"qPCR, Western blot, other",up-regulated,30463652.0,Also Known As: U87HG; HBII-276HG; NCRNA00058,4,"NR_002599.2, NR_152598.1, NR_152599.1, NR_152600.1","4, 5, 3, 5","4,5,3,5","0,0,0,0","0,0,0,0",VALIDATED,"0;

0;

0;

0","0;

0;

0;

0",No PQS found in G4 Hunter,"0;

0;

0;

0","0;

0;

0;

0",No PQS found in G4 Hunter,,U87HG; HBII-276HG; NCRNA00058
SNHG7,nasopharyngeal cancer,"qPCR, Western blot etc",up-regulated,32218823.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G);

3 (1 - 2G, 2 - C-rich);

2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];

[0.826 (2G); -0.957,  -0.911 (C-rich)];

[0.826, 0.8 (2G)] ",No similarity to PQS (2G) from QGRS mapper,"3 (3G);

2 (3G);

2 (3G)","[1.348, 1.292, 1.444 (3G)];

[1.348, 1.292 (3G)];

[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",,NCRNA00061
SNHG7,nasopharyngeal cancer,"RT-qPCR, Western blot analysis, Dual luciferase reporter gene assay",up-regulated,31944163.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G);

3 (1 - 2G, 2 - C-rich);

2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];

[0.826 (2G); -0.957,  -0.911 (C-rich)];

[0.826, 0.8 (2G)] ",No similarity to PQS (2G) from QGRS mapper,"3 (3G);

2 (3G);

2 (3G)","[1.348, 1.292, 1.444 (3G)];

[1.348, 1.292 (3G)];

[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",,NCRNA00061
SNHG7,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown",down-regulated,31364118.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G);

3 (1 - 2G, 2 - C-rich);

2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];

[0.826 (2G); -0.957,  -0.911 (C-rich)];

[0.826, 0.8 (2G)] ",No similarity to PQS (2G) from QGRS mapper,"3 (3G);

2 (3G);

2 (3G)","[1.348, 1.292, 1.444 (3G)];

[1.348, 1.292 (3G)];

[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",,NCRNA00061
SOX2-OT,laryngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc",up-regulated,32266028.0,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18,16,13,16,15,11","0,0,0,0,0,0","0,0,0,0,0,0",REVIEWED,"5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

3 (1 - 2G, 2 - C-rich);

5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

2 (C-rich)","[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.764 (2G), -0.811, -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[-0.811, -0.6 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,SOX2OT; NCRNA00043
SOX2-OT,laryngeal squamous cell cancer,qPCR,up-regulated,30811870.0,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18,16,13,16,15,11","0,0,0,0,0,0","0,0,0,0,0,0",REVIEWED,"5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

3 (1 - 2G, 2 - C-rich);

5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

2 (C-rich)","[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.764 (2G), -0.811, -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[-0.811, -0.6 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,SOX2OT; NCRNA00043
SOX2-OT,nasopharyngeal cancer,"qRT-PCR, RIP etc.",up-regulated,31099048.0,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18,16,13,16,15,11","0,0,0,0,0,0","0,0,0,0,0,0",REVIEWED,"5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

3 (1 - 2G, 2 - C-rich);

5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

2 (C-rich)","[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.764 (2G), -0.811, -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[-0.811, -0.6 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,SOX2OT; NCRNA00043
SOX2-OT,laryngeal squamous cell cancer,"Microarray, qPCR etc.",up-regulated,28033431.0,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18,16,13,16,15,11","0,0,0,0,0,0","0,0,0,0,0,0",REVIEWED,"5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

3 (1 - 2G, 2 - C-rich);

5 (3 - 2G, 3 - C-rich);

5 (3 - 2G, 3 - C-rich);

2 (C-rich)","[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.764 (2G), -0.811, -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[0.911, 0.933,  0.915 (2G), -0.811,  -0.6 (C-rich)];

[-0.811, -0.6 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,SOX2OT; NCRNA00043
SOX21-AS1,oral squamous cell carcinoma,"qPCR, Cell migration and invasion assay, In vitro methylation etc.",down-regulated,27933111.0,,1,NR_046514.1,21,20,1,0,VALIDATED,"5 (1 - 2G, 4 - C-rich)
","[-0.911, -0.913, -1, -0.911 (C-rich), 0.746 (2G)]
 
","No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,SOX21 antisense divergent transcript 1;SOX21 antisense RNA 1 (non-protein coding);SOX21 antisense RNA 1;SOX21 antisense RNA 1 (head to head);NONHSAG013973.2;HSALNG0098682;HSALNG0098686;HSALNG0098688;HSALNG0098684;SOX21-AS1;NONHSAG013975.2;lnc-GPR180-2;HSALNG0098680
"SRRM2-AS 
SRRM2-AS1",nasopharyngeal cancer,"Western blot, Microarray",up-regulated,31742692.0,"Also known as: SRRM2-AS; 
SRRM2-AS1",2 (SRRM2-AS1),"SRRM2-AS1 (NR_027274.1, NR_027275.1)",,"12,9","1,0","0,0",VALIDATED (SRRM2-AS1),,,,,,,,SRRM2 antisense RNA 1;SRRM2 antisense RNA 1 (non-protein coding);CTD-2270P14.3;SRRM2-AS1;HSALNG0109055;NONHSAG018356.2
ST7-AS1,laryngeal squamous cell cancer,qPCR,up-regulated,30853182.0,Also Known As: ST7AS1; ST7OT1,1,NR_002330.1,15,11,4,0,VALIDATED,"13 (3 - 3G, 10 - C-rich)","

[-0.925, -0.924, -0.898,-0.87, -0.911, -0.868, -0.938, -0.911, -0.957, -0.811 (C-rich), 0.479, 0.911, 0.8 (3G)]
","PQS 8 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

By looking at PQS 8 and 9 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS.",2 (C-rich),"[-1.313, -1.4 (C-rich)] ","No similarity to PQS (2G) from QGRS mapper
",,ST7AS1; ST7OT1
STEAP3-AS1,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,,1,NR_046721.1,21,21,0,0,VALIDATED,5 (C-rich),"[-0.956, -0.915, -0.91, -0.734, -0.913 (C-rich)] ",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,STEAP3 antisense RNA 1;STEAP3 antisense RNA 1 (non-protein coding);NONHSAG029088.2;HSALNG0018314;STEAP3-AS1
THOR,nasopharyngeal cancer,"qPCR, Western blot, RIP, Luciferase reporter assay, etc.",down-regulation,29959065.0,Also Known As: THORLNC; THOR,1 (THORLNC),THORLNC (NR_144530.1),4 (THORLNC),4,0,0,VALIDATED (THORLNC),0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,THOR
THOR,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,29959065.0,Also Known As: THORLNC; THOR,1 (THORLNC),THORLNC (NR_144530.1),4 (THORLNC),4,0,0,VALIDATED (THORLNC),0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,THOR
THOR,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown, RIP, etc.",up-regulated,30503558.0,Also Known As: THORLNC; THOR,1 (THORLNC),THORLNC (NR_144530.1),4 (THORLNC),4,0,0,VALIDATED (THORLNC),0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,THOR
THOR,tongue squamous cell carcinoma,"qPCR, Western blot, in vitro knockdown, RIP",up-regulated,31220513.0,Also Known As: THORLNC; THOR,1 (THORLNC),THORLNC (NR_144530.1),4 (THORLNC),4,0,0,VALIDATED (THORLNC),0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,THOR
TSPEAR-AS1,tongue squamous cell carcinoma,RNA-seq,differential expression,30755833.0,Also Known As: C21orf31,1,NR_103707.1,30,30,0,0,VALIDATED,"10 (2 - G, 8 - C-rich)","[0.786, 0.791 (G), -0.741, -0.962, -0.872, -0.911, -0.88, -0.88, -0.875, -0.935 (C-rich)]","No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,C21orf31
TUC338,tongue squamous cell carcinoma,"qPCR, RNAi, Cell proliferation assay etc.",up-regulated,27637778.0,"Also Known As: TUC.338, TUC338, uc.338 (PCBP2-OT1)",1 (PCBP2-OT1),NR_109828.1 (PCBP2-OT1),5(PCBP2-OT1),5,0,0,VALIDATED (PCBP2-OT1),3 (C-rich),"[-0.872, -0.641, -0.845 (C-rich)] ",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,TUC338; uc.338; TUC.338
TUG1,oral squamous cell carcinoma,"qPCR, Western blot",up-regulated,30980391.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,laryngeal cancer,qPCR,up-regulated,30916820.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30581000.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,tongue squamous cell carcinoma,qPCR etc.,up-regulated,28597931.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,oral squamous cell carcinoma,"qPCR, RNAi, Western blot, Luciferase reporter assay, MTT assay etc.",up-regulated,28119088.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,oral squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay",up-regulated,28979812.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31,30,30,12,12,30,30,31","4,4,4,0,0,4,4,4","0,0,0,0,0,0,0,0",REVIEWED,"8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
3 (1 - 2G, 2 - C-rich);
 
3 (1 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich);

8 (7 - 2G, 1 - C-rich);
 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933 (2G),  -0.875, -0.918 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)];

[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G), -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);

5 (3G);

5 (3G);

0;

0;

5 (3G);

5 (3G);

5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

0; 

0; 

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];

[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",,taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
U47924.27,nasopharyngeal cancer,"Microarray, qPCR etc.",down-regulated,27886062.0,Also Known As: U47924.27,1,NR_135032.1,5,5,0,0,VALIDATED,1 (2G),[0.873 (2G)],"No similarity to PQS (2G) from QGRS mapper
",0,0,No PQS found in G4 Hunter,,U47924.27
UCA1,oral squamous cell carcinoma,"qRT-PCR, Western blot",up-regulated,32130788.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,nasopharyngeal cancer,"qPCR, western blot",up-regulated,31537148.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,laryngeal squamous cell cancer,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30679991.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,tongue cancer,"qPCR, Luciferase reporter assay, RIP, etc.",up-regulated,30635938.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay, etc.",up-regulated,30498361.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,hypopharyngeal carcinoma,"qPCR, RNAi, Cell cycle assay, Cell migration and invasion assay etc.",up-regulated,28327194.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,tongue squamous cell carcinoma,"qPCR, Western blot etc.",up-regulated,29441929.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,tongue squamous cell carcinoma,qPCR etc.,up-regulated,24332332.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,oral squamous cell carcinoma,qPCR etc.,up-regulated,23292713.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,oral squamous cell carcinoma,"qPCR, Luciferase reporter assay, Western blot",up-regulated,29125238.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,oral squamous cell carcinoma,"qPCR, Cell transfection, Cell migration and invasion assay etc.",up-regulated,27560546.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
WWTR1-AS1,head and neck squamous cell carcinoma,"qRT-PCR , Western blot , in vitro knockdown etc.",up-regulated,31172583.0,,1,NR_040250.1,15,13,2,0,VALIDATED,"4 (1 - 2G, 1 - 3G, 2 - C-rich)
","[-0.864, -0.849 (C-rich), 0.926 (2G), 0.913 (3G)]","
PQS 3 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.
",0,0,No PQS found in G4 Hunter,,WWTR1 antisense RNA 1;WWTR1 antisense RNA 1 (non-protein coding);WWTR1-AS1;NONHSAG036362.2;HSALNG0029752
XIST,laryngeal squamous cell cancer,"qRT-PCR, Western blot",up-regulated,32149330.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,nasopharyngeal cancer,"qPCR, Western blot, luciferase reporter assay etc",up-regulated,32196601.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,laryngeal squamous cell cancer,"RT-PCR, luciferase reporter assays, Western blot analysis",up-regulated,31894287.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,nasopharyngeal cancer,"RT-qPCR, Western blot assay, Luciferase reporter assay, RIP",up-regulated,31810117.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,laryngeal squamous cell cancer,"qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc.",up-regulated,31071316.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, Western blot etc.",up-regulated,28985197.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,nasopharyngeal cancer,"qPCR, Western blot etc.",up-regulated,29219216.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,nasopharyngeal cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,27461945.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891 (C-rich), 0.933, 0.836, 0.891, 0.772 (2G)]",No similarity to any PQS (2G) from QGRS mapper,9 (C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
ZEB2-AS1,head and neck squamous cell carcinoma,"qPCR, Western blot",up-regulated,30950191.0,Also Known As: ZEB2AS; ZEB2-AS; ZEB2NAT,1,NR_040248.2,4,4,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,,ZEB2AS; ZEB2-AS; ZEB2NAT
ZFAS1,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,29917194.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZFAS1,nasopharyngeal cancer,"Microarray, qRT-PCR, Dual luciferase reporter assay, Western blot analysis",up-regulated,31851778.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZFAS1,head and neck squamous cell carcinoma,RT-PCR etc.,up-regulated,31010087.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZFAS1,nasopharyngeal cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,31403940.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZFAS1,nasopharyngeal cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,31307201.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZFAS1,nasopharyngeal cancer,"qPCR, Western blot, etc.",up-regulated,29917194.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11,8,10,11,4","2,1,2,2,0","0,0,0,0,0",REVIEWED,"2 (2G);

1 (2G);

2 (2G);

2 (2G);

0","[0.774, 0.628 (2G)];

[0.774 (2G)];

[0.774, 0.628 (2G)]; 

[0.774, 0.628 (2G)]; 

0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);

3 (3G);

3 (3G);

3 (3G);

0","[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)]; 

[1.444, 1.438, 1.333 (3G)];

0",No similarity to PQS (3G) from QGRS mapper,,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
ZNF561-AS1,laryngeal squamous cell cancer,qRT-PCR,down-regulated,32174248.0,Also Known As: C19orf82,1,NR_122038.1,11,10,1,0,VALIDATED,"5 (2 - 3G, 3 - C-rich)","[0.791, 0.965 (3G), -0.773, -0.872, -1 (C-rich)]","PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

By looking at PQS 1 and 2 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",1(3G),[1.4 (3G)],"PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.


PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.",,C19orf82
ZNF667-AS1,laryngeal squamous cell cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",down-regulated,30684967.0,Also Known As: ZNF667-AS1; MORT,2,NR_036521.1; NR_036522.1,"10,5","9,4","1,1","0,0",VALIDATED,"7 (2 - 2G, 3 - 3G, 2 - C-rich);

7 (2 - 2G, 3 - 3G, 2 - C-rich)","[0.958, 1, 1.04, 0.911, 0.733 (3G); -0.933, -0.776 (C-rich)];

[0.958, 1, 1.04, 0.911, 0.733 (3G); -0.933, -0.776 (C-rich)]",No similarity to PQS (3G) from QGRS mapper,"1 (3G);

1 (3G)","[1.422 (3G)];

[1.422 (3G)]",No similarity to PQS (3G) from QGRS mapper,,MORT
ZNF674-1,nasopharyngeal cancer,"Microarray, qPCR etc.",up-regulated,24822202.0,,2,"NR_110388.1, NR_036522.1","1,5","1,4","0,1","0,0",VALIDATED,"0;

7 (2 - 2G, 3 - 3G 2 - C-rich)","0;

[0.958, 0.911 (2G) 1, 1.04, 0.733 (3G),  -0.933, -0.776 (C-rich)]","No similarity to PQS (3G) from QGRS mapper
","0;

1 (3G)","0;

[1.422 (3G)]","No similarity to PQS (3G) from QGRS mapper
",,long intergenic non-protein coding RNA 1186;ZNF674-1;HSALNG0137635;LINC01186;HSALNG0137632;NONHSAG054355.2
ZNF674-1,nasopharyngeal cancer,qPCR etc.,up-regulated,29805695.0,,2,"NR_110388.1, NR_036522.1","1,5","1,4","0,1","0,0",VALIDATED,"0;

7 (2 - 2G, 3 - 3G 2 - C-rich)","0;

[0.958, 0.911 (2G) 1, 1.04, 0.733 (3G),  -0.933, -0.776 (C-rich)]","No similarity to PQS (3G) from QGRS mapper
","0;

1 (3G)","0;

[1.422 (3G)]","No similarity to PQS (3G) from QGRS mapper
",,long intergenic non-protein coding RNA 1186;ZNF674-1;HSALNG0137635;LINC01186;HSALNG0137632;NONHSAG054355.2
ZNF674-1,nasopharyngeal cancer,"qPCR, in vitro knockdown",down-regulated,29805695.0,,2,"NR_110388.1, NR_036522.1","1,5","1,4","0,1","0,0",VALIDATED,"0;

7 (2 - 2G, 3 - 3G 2 - C-rich)","0;

[0.958, 0.911 (2G) 1, 1.04, 0.733 (3G),  -0.933, -0.776 (C-rich)]","No similarity to PQS (3G) from QGRS mapper
","0;

1 (3G)","0;

[1.422 (3G)]","No similarity to PQS (3G) from QGRS mapper
",,long intergenic non-protein coding RNA 1186;ZNF674-1;HSALNG0137635;LINC01186;HSALNG0137632;NONHSAG054355.2
"Total no. of 
LncRNAs having 
Validated and 
Reviewed 
RefSeq status",,,,,,,,,,,,,,,,,,,,
164,,,,,,,,,,,,,,,,,,,,
